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For many liver malignancies, major hepatectomy is the main course of therapy. Although 
a normal liver has a tremendous capacity for regeneration, liver hepatectomy in humans 
is usually carried out on a diseased liver and in such instances, liver regeneration takes 
place in a cirrhotic remnant. As the demand of energy increases during liver regeneration, 
the mitochondria must play an important role. Cytokines and growth factors also play 
important roles in liver regeneration. Hepatocytes need to be primed before they are 
competent to respond to growth factors and proliferate. Cytokines such as TNF-α and IL-
6 can prime the hepatocytes, making them go from quiescent phase to G1 phase. 
Following this, the growth factors HGF and TGF-α act as mitogens and the hepatocytes 
respond by progressing through the cell cycle resulting in cell division. Cyclins such as 
cyclin D1, D3, E and A and their respective cyclin-dependant kinase partners play 
important roles at different phases of the cell cycle and regulate progress through the cell 
cycle. The activities of cdks can be inhibited by cdk inhibitors such as p21 and p27. 
 
 This study aims to investigate how mitochondrial respiratory function, antioxidant 
capacity, cytokines, growth factors, cyclins, cdks and cdk inhibitors expressions change 
following partial hepatectomy of cirrhotic livers. Cirrhosis was induced in male Wistar-
Furth rats by administration of thioacetamide. NADH-cytochrome c reductase activity, 
glutathione peroxidase activity and mitochondrial GSH levels were all significantly 
lowered in cirrhotic livers and in the cirrhotic remnants up to 72 h after 70% hepatectomy 
when compared to the corresponding controls. Lower respiratory control ratios with 
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succinate as substrate were also observed at 6 h till 48 h post-hepatectomy. At 24 h post-
PH, higher levels of lipid peroxidation were observed. Cirrhotic rats had decreased 
cytosolic IL-6 level till 72 h post-hepatectomy. Cirrhotic rats also had lower expressions 
of cyclin D1 from 24 h to 72 h; cyclin D3 at 24 h; cdk4 from 6 h to 72 h; cylcin E till 72 
h; cyclin A and cdk 2 from 24 h to 48 h post-hepatectomy. But the mRNA levels of p21 
at 3 h and p27 from 6 h to 48 h were up regulated in cirrhotic rats.  
 
In conclusion, when compared to the controls, cirrhotic livers have diminished oxidative 
phosphorylation capabilities due to changes in NADH-linked and FADH2-linked 
respiration as well as impaired antioxidant defenses following partial hepatectomy. 
Cirrhotic livers also have diminished cytokines, cyclins, cdks expression but increased 
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Hepatocellular carcinoma is the third most common cause of death due to cancer 
worldwide (Parkin DM et al, 2001). In humans, liver resection is the main therapeutic 
procedure for liver diseases such as hepatocellular carcinoma. In such cases, the remnant 
liver is often cirrhotic and is less competent in regenerating with a significant risk of liver 
failure (Franco D et al, 1990). Impaired liver regenerative capacity was also observed in 
cirrhotic rats with lower proliferating cell nuclear antigen labeling index and expression 
of G1 regulatory cell cycle-related proteins (Yanagida H et al, 2005; Ozdogan M et al, 
2005; Kato A et al, 2005). In this study, we aim to examine the differences in the 
responses of normal and cirrhotic livers to partial hepatectomy in relation to the factors 
influencing liver regeneration. 
 
1.1 Liver 
Liver is the largest organ in the body. It has many important functions, such as the 
formation and secretion of bile, nutrient and vitamin metabolism, inactivation of various 
substances, synthesis of plasma proteins and it also plays a role in immunity (Ganong W. 





1.1.1 Liver regeneration 
As punishment for stealing fire and giving it to humans, the Greek god Zeus banished 
Prometheus to be chained to a rock on Mt. Caucasus. As part of his punishment, an eagle 
would peck out his liver daily, and every night his liver would regenerate. As mythical as 
the story is, it illustrates the remarkable ability of liver to regenerate. 
 
Hepatocytes rarely divide in their normal state. After surgical removal of tissue or cell 
loss caused by chemicals or viruses, hepatocytes proliferate and the liver adapts to 
variable metabolic demands (Fausto N, 2000). 
 
For the regeneration process to occur, a large number of immediate early genes are first 
expressed. Hepatocytes need to be primed before they can respond to the growth factors 
hepatocyte growth factor (HGF), transforming growth factor α (TGF-α) and epidermal 
growth factor (EGF). Priming requires tumor necrosis factor (TNF), interleukin-6 (IL-6) 
and cytotoxicity preventing agents (Fig 1.1). TNF has either proliferative or apoptotic 
effect on hepatocytes. This depends on the reactive oxygen species (ROS) and 
glutathione content (Fausto N, 2000). Partial hepatectomy in rodent is the best 
experimental model to study liver regeneration. At least four transcription factors NFκB, 
AP-1, C/EBPβ and STAT3 are activated after partial hepatectomy (Tewari M et al, 1992; 
FitzGerald M et al, 1995; Cressman DE et al, 1995; Diehl AM et al, 1994; Rana B et al, 
1995 and Greenbaum LE et al, 1998). 
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NFκB is found both in hepatocytes and in non-parenchymal cells (FitzGerald M et al, 
1995). It is a hetero-dimer consisting of two subunits p65 and p50 (Tewari, M et al, 1992 
and FitzGeral M et al, 1995). The hetero-dimer is retained in the cytoplasm when the 
inhibitor IκB is bound to the p65 subunit. After partial hepatectomy, IκB is 
phosphorylated, ubiquitinated and digested by proteasome complex. The NFκB hetero-
dimer then translocates to the nucleus and activates gene expression (Fig 1.2). 
 
Table 1.1 Principle functions of the liver.  
Formation and secretion of bile 
Nutrient and vitamin metabolism 
    Glucose and other sugars 
    Amino acids 
    Lipids 
        Fatty acids 
        Cholesterol 
        Lipidproteins 
    Fat-soluble vitamins 
    Water-soluble vitamins 
Inactivation of various substances 
    Toxins 
    Steroids 
    Other hormones 
Synthesis of plasma proteins 
    Acute-phase proteins 
    Albumin 
    Clotting factors 
    Steroid-binding and other hormone-binding proteins 
Immunity 
    Kupffer cells 
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Fig 1.1 Multistep model of liver regeneration (modified from Fausto N, 2000). Liver 
regeneration is divided into two phases, priming phase and cell cycle progression phase. 
The priming phase is a reversible process initiated by cytokines as well as nutritional and 
hormonal signals. Priming sensitizes the cell to growth factors. Growth factors are 
required for cells to move beyond a restriction point in G1.  
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Fig 1.2 Mechanisms of NFκB activation (modified from Fausto N, 2000). NFκB is a 
transcription factor. TNF activates NFκB through the production of ROS in the liver. The 
critical step of NFκB activation is the dissociation of the inhibitor IκB from the NFκB 
heterodimer formed by the p65 and p50 subunits. The IKK complex phosphorylates IκB 
and initiates its degradation. NFκB heterodimer, free of the inhibitor, migrates to the 





1.1.2 Partial hepatectomy 
Partial hepatectomy (Higgins GM et al, 1931) is the best experimental model for the 
study of liver regeneration. It is a simple operation that results in two-thirds of the liver of 
a rat being removed. The median and left lateral lobes (the external portion of the liver) 
are removed, without damage to the remaining lobes. The residue lobes enlarge to make 
up for the mass of the removed lobes, but the resected lobes never grow back. The whole 
regeneration process lasts 5 to 7 days in the rat.  
 
After partial hepatectomy, all the remaining mature cells divide. These include 
hepatocytes, epithelial cells, fenestrated endothelial cells, Kupffer cells and Ito cells. 
Hepatocytes proliferate first. Since two-thirds of the liver has been removed, restoration 
of the original number of hepatocytes requires 1.66 cell cycles per residual hepatocyte. 
However, not all the hepatocytes will undergo cell division. In young rats, 95% 
hepatocytes will undergo division, while the rest of the hepatocytes do not proliferate and 
maintain the functions of the liver. For very old rats, fewer hepatocytes (~75%) will 
divide (Fausto N, 2000). 
 
1.2 Experimental model of liver cirrhosis 
1.2.1 Liver cirrhosis 
Normal livers are those with a normal hepatic architecture with no abnormal  
collagen deposition. Fibrosis is defined either as a moderate collagen accumulation with  
portal sclerosis or as an invasion of the parenchyma by fibrous tracts but without  
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regeneration nodules. Cirrhosis is defined as the breakdown of normal hepatic 
architecture and the formation of regeneration nodules as a result of fibrous septa 
interconnecting the portal spaces or the portal spaces with central lobular areas (Cabre M 
et al, 2000).  
 
Hepatic fibrosis is a wound-healing process for chronic injury. Alcohol, hepatitis, 
schistosomiasis, biliary atresia, malnutrition, carcinogens and hepatotoxins can all cause 
inflammatory reactions in the liver. The damaged hepatocytes, their membrane 
components, metabolites of toxic agents, and infiltrating inflammatory cells will activate 
Kupffer cells. The activated Kupffer cells then release a number of soluble agents, 
including cytokines, such as TGF-β, platelet-derived growth factor, TNF-α, and other 
factors. These factors activate hepatic stellate cells (HSC). HSC are normally quiescent 
and produce small amounts of extracellular matrix (ECM) components. When they are 
exposed to factors from damaged hepatocytes and activated Kupffer cells, HSC lose their 
lipid content (retinyl palmitate), and become myofibroblast-like cells. The activated HSC 
will then produce large amounts of ECM components (Wu J et al, 2000). 
 
Hepatic fibrosis is the result of disequilibrium between synthesis and degradation of  
ECM components (Biagini G et al, 1989 and Arthur MJ, 1995). After tissue injury, TGF-
β is released (Milani S et al, 1994; Bissell DM, 1990 and Border WA et al, 1994). It 
induces ECM deposition by stimulating the synthesis of new matrix components, 
increasing the synthesis of ECM degradation inhibiting enzymes, and decreasing the 
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synthesis of matrix-degrading proteases (Milani S et al, 1994; Edwards DR et al, 1987; 
Iredale JP et al, 1996 and Weiner FR et al, 1990). 
 
When the liver insult is chronic and deposition of ECM components increases, liver 
fibrosis eventually progresses to cirrhosis with nodule formation (Bissell DM et al, 1990). 
 
1.2.2 Thioacetamide induced cirrhosis in rat 
Animal models are usually used to study liver fibrosis and cirrhosis. The ideal animal 
model should: (a) have similar morphologic features to the human disease being studied; 
(b) having a gradual and discrete progression of change in the liver pathology; (c) be 
highly reproducible with a low mortality rate; (d) be reversible or irreversible, depending 
on the nature of the study and (e) develop pathophysiologic sequelae (Tsukamoto H et al, 
1990). 
 
The rat has been used as an experimental model to study hepatic fibrosis and cirrhosis. 
The experimental models of hepatic fibrosis and cirrhosis in the rat can be categorized by 
the aetiologic factor, namely hepatotoxins, nutritional, immunologic and biliary. The 
commonly used models are thioacetamide, carbon tetrachloride (CCl4), alcohol or bile 
duct ligation induced cirrhosis in rats. CCl4 is activated by oxidases to yield 
trichloromethyl (CCl3) free radical. This reactive free radical can damage lipids and 
proteins and cause liver injury. However CCl4 induced cirrhosis is reversible and CCl4 
can cause fatty change in hepatocytes (Proctor E et al, 1982). The aversion of rats to 
alcohol requires the implantation of gastric catheters and makes the cirrhosis induction 
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difficult. The bile duct ligation model involves operating on the animal. It is therefore 
experimentally more challenging. The procedure is more traumatic to the animal and the 
mortality rate is high. Hepatic fibrosis may be absent and the induced cirrhosis is 
reversible (Wasser S et al, 1999). Of the various models of cirrhosis, the histology of 
thioacetamide model is more akin to that of human cirrhosis (Zimmermann T et al, 1987 
and Dashti H et al, 1989) and the cirrhosis is stable for two months after discontinuation 
of the drug (Wasser S et al, 1999). 
 
Thioacetamide, originally used as a fungicide is now used as a hepatotoxicant. After 
being administrated, thioacetamide forms a sulfone by the hepatic mixed – function 
oxidase system including cytochrome P450 (Hunter AL et al, 1977). This sulfone binds 
to proteins and forms acetyl – imidolysine derivatives (Dyroff MC et al, 1981). These 
derivatives may be partially responsible for the thioacetamide – induced hepatotoxic 
effects. 
 
1.3 Mitochondrial oxidative phosphorylation 
Mitochondria are eukaryotic oxidative metabolism organelles. They are typically oval-
shaped, 1 μm in length and 0.5 μm in diameter. A eukaryotic cell may contain up to 2000 
mitochondria. Mitochondria have the respiratory chain assembly, citric acid cycle 
enzymes and enzymes involved in fatty acid oxidation.  
 
The mitochondrion has an outer membrane, a folded inner membrane, an intermembrane 
space between the two membranes and the matrix enclosed by the inner membrane. 
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Electron transport and oxidative phosphorylation occur in inner membrane. The citric 
acid cycle and fatty acid oxidation take place in the matrix. The matrix also contains 
DNA, RNA and ribosomes. The outer membrane has porins and is permeable to small 
molecules. The inner membrane is only permeable to O2, CO2 and H2O. There are 
transporters in the inner membrane to control the permeability of metabolites and ions. 
This allows for the generation of ionic gradients across the membrane.  
 
Most energy in animal cells is generated by mitochondria through oxidative 
phosphorylation. During this process, electrons are transferred along the electron 
transport chain. The electrons are generated from NADH, which is produced by oxidation 
of nutrients such as glucose and fatty acids. The electron transport chain contains four 
respiratory enzyme complexes (complex I - complex IV). The transportation of electrons 
between these complexes releases energy. The energy is stored in a proton gradient 
across the inner membrane of mitochondria. The energy stored in the gradient is 
harnessed to make ATP from ADP and phosphate (Saraste M, 1999 and Fig 1.3).  
 
1.3.1 Complex I 
Complex I is also called NADH: ubiquinone oxidoreductase. It catalyzes the reversible 
reaction: 
 
NADH + Q + H+ + 4 H+matrix                          NAD+ + QH2 + 4 H+intermembrane space 
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This reaction provides NAD+ for the Krebs cycle. It also contributes to the proton 
gradient across the inner membrane, which is the driving force for ATP synthesis.  
 
Mammalian Complex I has 42 or 43 subunits, one flavin mononucleotide, seven or eight 
FeS centers, covalently bound lipid and at least three bound quinols (Walker JE, 1992; 
Skehel JM et al, 1998; Friedrich T et al, 1995 and Brandt U, 1997).  
 
1.3.2 Complex II 
Complex II is also called succinate: ubiquinone reductase. It catalyzes the following 
reaction: 
succinate                       fumarate + 2 H+ + 2 e- 
 
Complex II oxidizes succinate to fumarate and transports electrons from succinate to the 
ubiquinone pool. It is the only direct link between citric acid cycle and the electron 
transport chain in the inner mitochondrial membrane (Ackrell BA, 2000).  
 
Complex II has FAD (flavin-adenine dinucleotide) and FeS centers, and is anchored to 
the membrane by a b-type cytochrome. It does not pump protons and only feeds electrons 
to the electron transport chain (Hagerhall C, 1997).  
 
1.3.3 Complex III 
Complex III is also called cytochrome bc1. It transports electrons from ubiquinol (QH2) to 
cytochrome c and generates a proton gradient across the inner mitochondrial membrane 
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via the Q cycle. The reaction catalyzed by complex III is described by the following 
equation:  
 
QH2 + 2 H+matrix + 2 cyt cox                         Q + 4 H+intermembrane space + 2 cyt cred
 
Ubiquinol is lipid-soluble and can translocate within the inner mitochondrial membrane. 
When ubiquinone (Q) is reduced, it takes up protons from the matrix. When ubiquinol is 
oxidized, it releases protons to the intermembrane space. Complex III transports two 
electrons from ubiquinol to two molecules of cytochrome c, deposits two protons from 
ubiquinol in the intermembrane space, and transfers another two protons from the matrix 
to the intermembrane space per pair of electrons transferred (Trumpower BL, 1990).  
Mammalian Complex III has eleven subunits and three of them carry the redox centers 
and conserve energy. The key subunits are cytochrome b with eight transmembrane 
helices, two hemes, membrane –anchored FeS protein and cytochrome c1 with one heme. 
The other eight subunits are small proteins (Saraste M, 1999). 
 
1.3.4 Cytochrome c oxidase 
Cytochrome c oxidase is also called complex IV. It is the terminal enzyme complex of 
the electron transport chain. Cytochrome c oxidase catalyzes the oxidation of 
ferrocytochrome c to ferricytochrome c, while the reduction of oxygen to water by a four-
electron process takes place. Protons are pumped from the matrix of mitochondria to the 
intermembrane space (Wikstrom MK 1977 and Chan SI et al, 1990). A proton 
electrochemical gradient is thus generated, such that the intermembrane space is positive 
 27
and acidic relative to the matrix. The overall stoichiometry is summarized by the 
following equation: 
 
4 cyt cred + O2 + 8 H+matrix                       4 cyt cox + 2 H2O + 4 H+intermembrane space
 
Eight protons per O2 are taken up from the matrix, four of which are used to react with 
cytochrome c at the outside surface of cytochrome c oxidase to form H2O. The protons 
and electrons used to form H2O are from opposite side of the membrane, so the reaction 
results in the transportation of four protons across the membrane per O2 and the 
generation of a transmembrane potential. Cytochrome c oxidase pumps four protons per 
O2 electrogenenically, one proton per electron. Altogether eight protons are transported 
across the membrane per O2. The pH gradient and membrane potential are used for ATP 
synthesis by F1F0 ATP synthase (Gennis RB, 1998). 
Mammalian cytochrome c oxidase has 13 subunits, four redox-active metal sites (hemes a 
and a3, CuA and CuB), three redox-inactive metal sites (Mg2+, Zn2+ and Na+) and several 
phospholipids (Tsukihara T et al, 1996). 
 
1.3.5 ATP synthase 
Mitochondria F1F0 ATP synthase is also called complex V. It is a functionally reversible 
enzyme. It can synthesize most of the cellular ATP from ADP and phosphate, using the 
proton gradient across the mitochondrial inner membrane.  
 
ADP + Pi                      ATP 
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The ATP synthase consists of a water-soluble F1 portion and a transmembrane F0 portion. 
Proton transport through F0 releases ATP on F1 by conformational changes. F1 consists of 
five subunit types in an α3 β3γ 1δ1ε 1 stoichiometry, with a ring of α and β subunits 
alternating around a single γ subunit (Abrahams JP et al, 1994). Differential interactions 
of the three β subunits with the γ subunit induce asymmetry at the three catalytic sites. 
The catalytic sites on each of the three β subunits cycle between three binding states for 
substrates and products in an "alternating sites" mechanism (Weber J et al, 1997 and 
Boyer PD, 1997).  
 
F0 consists of three subunit types in an a1b2c12 stoichiometry (Jones PC et al, 1998). The 
twelve c subunits are arranged in an annular manner, with subunits a and b2 on the 
periphery of the cylinder. The subunit b dimmer links subunit a of F0 with the δ subunit 
and one of the α subunits of F1. The ring of c subunits has contact with subunit a in F0. 
The subunit c ring is also linked to the γ subunit of F1 both directly and indirectly through 
the ε subunit (Hermolin J et al, 1999). 
 
1.4 Oxidative stress 
1.4.1 Reactive oxygen species 
Mitochondria generate ROS as byproducts of oxygen consumption in the electron 
transport chain. Most of the oxygen is consumed in the cytochrome c oxidase of the 
respiratory chain, which does not generate ROS. The Q cycle is the major site within the 
respiratory chain that generates superoxide anion as a result of an electron being 
transferred to oxygen (Fernandez-Checa J et al, 1997 and Fig 1.4).  
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 NADH dehydrogenase and succinate dehydrogenase both will reduce ubiquinone to 
ubiquinol. Ubiquinol is oxidized to ubisemiquinone by transferring one electron to 
cytochrome bc1 catalyzed by the Rieske iron-sulfur center. Ubisemiquinone is oxidized to 
ubiquinone by the transfer of a second electron to cytochrome b-566. Cytochrome b-566 
then transfers this electron to cytochrome b-562, reducing ubisemiquinone to ubiquinol. 
When the last step is blocked, the electron is passed directly to oxygen, thereby 
generating superoxide anion (Turrens JF et al, 1985 and Turrens JF et al, 1980).  
 
An imbalance between the production of ROS and antioxidant capacity leads to a state of 
“oxidative stress” that contributes to the pathogenesis of a number of human diseases. 
Oxidative stress is a result of increased exposure to oxidants or decreased antioxidants or 
both (Cadenas E, 1989). Lipid peroxidation is often used as a marker of oxidative stress. 
The oxidative destruction of cellular membranes occurs via an autocatalytic mechanism 
and leads to cell death and also to the production of toxic and reactive aldehyde 
metabolites called free radicals (Cheeseman, KH, 1993). Of these free radicals, 
malondiadehyde is the most important (Paradis V et al, 1997). 
 
Mitochondrion is one of the main sources of ROS. In addition this organelle is also a key 
target of ROS damage. ROS can damage macromolecules, including DNA, proteins, and 
lipids (Ames BN et al, 1993; Cerrutti PA, 1985; Shigenaga MK et al, 1994 and Stadtman 
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Fig 1.3 Profile of the mitochondrial electron transport-oxidative phosphorylation 
system (modified from Hatefi Y, 1985). Electrons from substrate oxidations feed into 
the electron transport chain at Complex I or Complex II and then flow to Complex III, 
Complex IV and finally to oxygen. Complex I, III and IV pump the protons out from the 
matrix, generating an electrochemical potential of protons (∆p) across the inner 
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Fig 1.4 The postulated Q-cycle mechanism of electron transfer in complex III of 
mitochondrial respiratory chain (modified from Turrens JF et al, 1985). NADH 
dehydrogenase and succinate dehydrogenase both will reduce ubiquinone (Q) to 
ubiquinol (QH2). Ubiquinol is oxidized to ubisemiquinone (QH-·) by transferring one 
electron to cytochrome bc1 catalyzed by the Rieske iron-sulfur center. Ubisemiquinone is 
oxidized to ubiquinone by the transfer of a second electron to cytochrome b-566. 
Cytochrome b-566 then transfers this electron to cytochrome b-562, reducing 
ubisemiquinone to ubiquinol. When the last step is blocked, the electron is passed 








Antioxidants provide the necessary defense against oxidant damage. There are 
nonenzymatic and enzymatic antioxidants. Vitamin E (α-tocopherol) is a major 
membrane-bound antioxidant. Other lipid-soluble antioxidants include β-carotene and 
ubiquinone. Vitamin C (ascorbic acid) is a major water-soluble antioxidant. Other water 
soluble antioxidants include uric acid, glutathione, ferritin and ceruloplasmin. Superoxide 
dismutase (SOD), glutathione peroxidase and catalase are antioxidant enzymes.  
 
1.4.2.1 Glutathione (GSH) 
GSH is L-γ-glutamyl-L-cysteinyl-glycine. It is synthesized from L-glutamate, L-cysteine, 
and glycine in two steps, catalyzed by γ-glutamyl-L-cysteine synthase and glutathione 
synthase (Griffith OW, 1999). The first enzymatic step is rate-limiting.  
 
GSH plays an important role in detoxification. It is utilized in redox and conjugation 
reactions leading to the elimination of free radicals (Mitchell JB et al, 1987; DeLeve LD 
et al, 1990 and Meister A, 1994). Glutathione peroxidase catalyzes redox reactions, 
oxidizing GSH to GSSG and reducing organic peroxides. Glutathione reductase restores 
the consumed GSH. Cytosolic and microsomal glutathione transferases catalyze 
conjugation reactions.  
 
Eukaryotic cells have three major reservoirs of GSH. Almost 90% of cellular GSH is in 
the cytosol, 10% in the mitochondria, and a small percentage in the endoplasmic 
reticulum (Hwang C et al, 1992 and Meredith MJ et al, 1982).  
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 Mitochondria do not contain γ-glutamylcysteine synthetase and glutathione synthetase. 
Thus, the mitochondria can not synthesize their own GSH (Griffith OW et al, 1985). The 
transport of GSH from cytosol to mitochondria is a carrier-mediated and ATP dependent 
process that overcomes the unfavorable entry against an electrochemical gradient 
(Cummings BS et al, 2000; Garcia-Ruiz C et al, 1995 and Martensson J et al, 1990). The 
dicarboxylate and 2-oxoglutarate carriers on the mitochondrial membrane have been 
shown to be GSH transporting polypeptides (Chen  Z et al, 1998; Chen Z et al, 2000 and 
Lash LH et al, 2002).  
 
1.4.2.2 Superoxide dismutase (SOD) 
SOD protects oxygen-metabolizing cells against damage by superoxide free–radicals. It 
catalyzes the destruction of O2. - free radical: 
 
2 O2. - + 2 H+                       H2O2 + O2 
 
Mammals have cytoplasmic and extracellular Cu, Zn-SOD and mitochondrial Mn-SOD.  
 
1.4.2.3 Glutathione peroxidase  
Mitochondrial glutathione peroxidase and cytosolic glutathione peroxidase are encoded 
by the same gene GPX-1 (Esworthy RS et al, 1997). Glutathione peroxidase is a 
selenoprotein catalyzing the reaction: 
 
 34
ROOH + 2 GSH                         GSSG +ROH + H2O 
 
Glutathione peroxidase detoxifies H2O2 and organic peroxides by reducing them to water 
and oxygen at the expense of GSH. The sulfhydryl moiety of cysteine supplies the actual 
reducing equivalent. Two molecules of GSH are oxidized to disulfide-bonded GS-SG 
during the reduction of one molecule of H2O2.   
 
1.4.2.4 Glutathione reductase 
Glutathione reductase is a flavoprotein. It has flavin adenine dinucleotide as the 
prosthetic group. It catalyzes the reaction: 
 
GSSG + NADPH + H+                          2 GSH + NADP+
 
Glutathione reductase reduces one molecule of GS-SG to two molecules of GSH at the 
expense of NADPH. Glutathione peroxidase is the companion enzyme of glutathione 
peroxidase. It permits the continuous action of glutathione peroxidase. 
 
1.4.2.5 Catalase 
Catalytic activity is present in nearly all animal cells and organs and aerobic 
microorganisms. Like glutathione peroxidase, catalase is also a hemoprotein and 
decomposes H2O2 to give H2O and oxygen.  
 
2 H2O2                         2 H2O + O2
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Catalase also oxidizes H donors, such as methanol, ethanol, formic acid and phenols, 
with consumption of H2O2. 
 
ROOH + AH2                         H2O + ROH + A 
 
1.5 Liver regeneration related proteins and genes 
Liver regeneration is influenced by a multitude of factors. It has now been established 
that a set of priming events is necessary before the normally quiescent hepatocytes can 
respond to the growth factors. Both TNF- α and IL-6 have been shown to be the factors 
that facilitate the priming events in regeneration. Following the priming events, growth 
factors then play an important role as mitogens generating a cascade of signals leading to 
DNA synthesis and cell division. The passage through the cell cycle is modulated by the 
interplay between cyclins, cyclin-dependent kinases (cdks) and inhibitors of cdks.   
 
1.5.1 Cell cycle 
Cell cycle can be divided into interphase and mitosis (M) phase.  
 
During interphase, the cell synthesizes RNA, produces proteins and grows in size. 
Interphase can be divided into Gap 0 (G0), Gap 1 (G1), synthesis (S) phase and Gap 2 
(G2).  In G0, the cell leaves the cycle and quits dividing. In G1, the cell increases in size, 
produces RNA and synthesizes proteins. There is a checkpoint in G1 to ensure that the 
cell is ready for DNA synthesis. During S phase, DNA is duplicated. In G2, the cell 
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continues to grow and produces proteins. There is another checkpoint at the end of G2 to 
determine if the cell can enter M phase and divide.  
During M phase, the cell stops growth and protein production and divides into two 
daughter cells. There is also a checkpoint in the middle of M phase to ensure the cell is 
ready to complete division.  
 
1.5.2 Priming role of TNF-α and IL-6 in liver regeneration 
Liver cells normally do not proliferate. They are at the quiescent G0 state. After 70% 
hepatectomy, hepatocytes enter cell cycle and divide once or twice. The transition of the 
quiescent hepatocyte into the cell cycle is priming, which involves the activation of NF-
κB and other transcription factors and their binding to DNA. This can be induced by 
TNF-α and IL-6.  
 
TNF-α is released from Kupffer cells. TNF-α is first produced as a 26 kDa 
transmembrane protein and stored in the Golgi area (Shurety W et al, 2000). It is then 
cleaved to give a 17 kDa active form and exists in solution as a 51 kDa homotrimer 
(Black RA et al, 1997). TNF-α has multiple functions (Baker SJ et al, 1996) and signals 
through two different receptors, 55 kDa TNFR-1 and 75 kDa TNFR-2. TNFR-1 is 
essential for liver growth. In TNFR-1 knockout mice, DNA replication is inhibited and 
death occurs at 24-40 h after PH. Increases in STAT3 and NF-κB binding do not occur 
either, and AP-1 binding is decreased (Yamada Y et al, 1997). 
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IL-6 is also secreted by Kupffer cells, and this secretion is stimulated by binding of TNF-
α to its receptors. IL-6 signals through its receptor. The receptor of IL-6 consists of an 80 
kDa IL-6 binding subunit and the 130 kDa signal transducer (Hirano T, 1998). Binding of 
IL-6 to gp80 induces disulfide-linked homodimerization of gp130 and elicits signal 
transduction (Murakami M et al, 1993). After hepatectomy, the plasma IL-6 
concentration increases and reaches high levels by 24 hours (Rai RM et al, 1996 and 
Matsunami H et al, 1992). In mice with disruption of the IL-6 gene, hepatocyte DNA 
synthesis during liver regeneration is suppressed. Activation of STAT3, AP1, Myc and 
cyclin D1 is also reduced. These are corrected by injection of exogenous IL-6 (Cressman 
DE et al, 1996). 
 
1.5.3 Role of HGF and TGF-α in liver regeneration 
During liver regeneration, DNA replication can only take place after the cells progress 
through the cell cycle. This requires growth factors such as HGF and TGF-α (Fausto N et 
al, 1995).  
 
HGF is a heterodimer composed of a 69 kDa α-subunit and a 34 kDa β-subunit 
(Nakamura T et al, 1987). They are located at the N-terminal and C-terminal of the same 
precursor respectively (Tashiro K et al, 1990). c-Met is the receptor of HGF. It has α and 
β subunits. The intracellular domain of the β subunit has tyrosine kinase activity and 
transduces all the effects of HGF. HGF and its receptor c-Met are important factors for 
liver growth and function. HGF knockout mice die at the embryo stage with arrested 
hepatic development (Uehyara Y et al, 1995 and Schmidt C et al, 1995). Two hours after 
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PH, rat plasma HGF concentrations rise 17-fold. This is followed by induction of DNA 
synthesis later in hepatocytes.  (Lindroos PM et al, 1991). HGF is also a potent mitogen 
for hepatocyte in culture (Nakamura T et al, 1989).  
 
TGF-α is an autocrine growth factor. It is synthesized by hepatocytes and exerts its effect 
on hepatocytes through the EGF receptor (Fausto N et al, 1995). It can also act through a 
juxtacrine mechanism, whereby TGF-α produced from one hepatocyte binds to the EGF 
receptor on another hepatocyte and has an effect on it. Cell adhesion is involved in this 
process. TGF-α is first produced as a transmembrane precursor. It is then cleaved and the 
50 amino acid single chain soluble TGF-α is released (Massague J, 1990). Binding of 
TGF-α to the 170 kDa EGF receptor activates the tyrosine kinase activity of the receptor 
and several intracellular substrates as well as the receptor is phosphorylated. Thus a 
cascade leading to DNA synthesis and cell duplication is triggered (Carpenter G et al, 
1990). TGF-α is present at high levels in newborn animals and declines while hepatocyte 
proliferation diminishes during the neonatal period (Fausto N et al, 1995). After 
hepatectomy, or CCl4 injury, and in hepatocyte primary culture, TGF-α levels increase 
(Webber EM et al, 1993). TGF-α knockout mice are normal (Russell WE et al, 1996). 
Since TGF-α shares the same receptor with EGF (Russell WE et al, 1998), there may be a 
compensatory increase of EGF.  
 
1.5.4 Role of cyclins, cdks and cdk inhibitors in cell cycle 
Cyclins control the cell cycle through binding to cdks. The progress through the cell 
cycle is activated by cyclin-cdk complexes through phosphorylation by CAK (Morgan 
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DO, 1997 and Grana X et al, 1995). Cyclin D binds cdk4 or cdk6 and is important in the 
early G1 phase. Cyclin E binds cdk2 and acts in the late G1 phase (Sherr CJ, 1996; Pines 
J, 1995 and Martin-Castellanos C et al, 1997). Cyclin A binds cdk2 and regulates the 
progression of DNA replication. Cyclin D1/cdk4 can phosphorylate pRb (Herwig S et al, 
1997) and other members of the pocket family (p107 and p130). This phosphorylation 
can free E2F transcription factors, leading to the activation of genes responsible for cell 
cycle progression from G1 to S phase. pRb is first phosphorylated by cyclin D1/cdk4 and 
the phosphorylation is accelerated by cyclin E/cdk2 (Herwig S et al, 1997).  
 
There are two families of cdk inhibitors. They are Ink4 family and Cip/Kip family (Sherr 
CJ et al, 1995). p16ink4a, p15ink4b, p18ink4c and p19ink4d are Ink4 members. They inhibit 
cdk4 and its homologue cdk6 by competing with cyclin D for binding. p21Cip1, p27Kip1 
and p57Kip2 are Cip/Kip members. They bind to many cyclin-cdk complexes, including 
cyclin D-cdk4/6, cyclin E-cdk2 and cyclin A-cdk2. Mice lacking p21Cip1 have more rapid 
progression through G1 phase after PH (Albrecht JH et al, 1998). Transgenic mice with 
high hepatic expression of p21Cip1 have impaired regeneration after PH. 
 
1.5.4.1 Structure of cdk2, cdk2-cyclin A and cdk2-cyclin A-p27 
Cdk2 has a β-sheet-rich amino-terminal lobe and a largely α-helical carboxy-terminal 
lobe with a deep cleft in between. The cleft is the binding site of ATP, and probably also 
the binding and catalysis site of protein substrates. Monomeric cdk2 is thought to be 
inactive, because the T-loop (residues 146-166) in the C-terminal lobe blocks the access 
of the substrate to the catalytic cleft, and the conserved cdk PSTAIRE helix in the smaller 
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N-terminal lobe misorients the side chains at the ATP binding site. Binding of cyclin A to 
cdk2 displaces the T-loop and allows entry to the catalytic cleft. The exposed T160 can 
be phosphorylated by CAK and cdk-cyclin complex is fully activated.  
Phosphorylation of T160 allows the T-loop to interact with a positive charged pocket 
formed after cyclin binds to cdk and stabilizes T-loop. Cyclin binding also reorients the 
PSTAIRE helix and allows the side chain in the catalytic site to orient appropriately.   
 
p27 has an N-terminal inhibitory domain that is sufficient to bind cdk-cyclin complexes. 
In the cdk2-cyclin A-p27 complex, p27 binds to both cyclin A and cdk2. The N-terminal 
of p27 interacts with cyclin A through a rigid coil containing the KIP/CIP conserved LFG 
motif. The coil binds a shallow groove in cyclin A formed by three α-helix of the cyclin 
conserved box. The C-terminal of p27 binds the N-terminal lobe and catalytic cleft of 
cdk2. p27 causes the change of cdk2 structure and inhibits cdk2 (Russo AA et al, 1996).  
 
1.5.5 p53 
p53 is a transcription factor. After insults, p53 can activate genes that are involved in 
apoptosis and growth arrest. p53 has a tetramerization domain. Four p53 molecules 
interact and form a tetramer, which binds to DNA (Jeffrey PD et al, 1995). The C 
terminal region consists mainly of basic residues predominantly and has regulatory 
properties. It can be modified by acetylation, phosphorylation, O-glycosylation and RNA 
binding. The SH3 binding domain is between the transcriptional activation domain and 
DNA binding domain (Gorina S et al, 1996). The acidic N-terminal is the transcriptional 
activation domain. This domain is also involved in regulating the stability and activity of 
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p53. It interacts with mdm2 and can be targeted for ubiquitin-mediated proteolysis 
(Haupt Y et al, 1997 and Kubbutat MH et al, 1997). p53 plays a dual role in liver 
regeneration (Inoue Y et al, 2002). The first is as a cell cycle check to allow damage 
repair (Kubin T et al, 1995). The second is the induction of the expression of growth 
factors or their receptors. p53 responsive elements have been found on the promoters of 
HGF and TGF-α (Shin TH et al, 1995 and Metcalfe AM et al, 1997). 
 
1.6 Objectives of this study 
For many liver malignancies including hepatocellular carcinoma, the main therapeutic 
intervention is surgical resection. Fibrotic or cirrhotic livers do not tolerate insults well 
and experience delayed regeneration following surgery. A lot of work has been done on 
regeneration of normal liver (Tsai J et al, 1992; Satoh S et al, 1996; Hernandez-Munoz R 
et al, 2003, Rininger JA et al, 1997; Ehrenfried JA et al, 1997; Albrecht JH et al, 1999 
and Jaumot M et al, 1999), but little has been done on cirrhotic liver. In 1999, when this 
study was started, most of the work was done on other cirrhotic models such as CCl4, 
alcohol and bile duct ligation induced cirrhosis (Napoli J et al, 1997; Hernandez-Munoz 
R et al, 1997 and Krahenbuhl S et al, 1989) rather than the thioacetamide induced model 
of cirrhosis.  
 
Our hypothesis is impaired capacity to respond to oxidative stress and to carry out 
oxidative phosphorylation as well as reduced expressions of cytokines, cyclins, cdks and 
increased expression of cdk inhibitors in cirrhotic livers have adverse effects on liver 
regeneration after hepatectomy. To verify this, the thioacetamide-induced rodent model 
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of liver cirrhosis was employed as induction of cirrhosis with thioacetamide is highly 
reproducible, irreversible and produces morphological features similar to that observed in 
human cirrhosis. The flow of the study is summarized in Fig 1.5. The excised and the 
remnant livers were collected and liver homogenates, the mitochondria and cytosolic 
fractions and total RNA were prepared and used for various assays.  






Sacrifice of rats at 3, 6, 24, 48, 72 hours post hepatectomy 
 
 
           Liver               RNA (RT-PCR for 28S rRNA, HGF, TGF-α, p21, p27, p53) 
 
                                  Mitochondria             Respiration (RCR, P/O, state 3, state 4) 
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                                                                     NCCR, CCO, GPx, GRd 
                                                                     GSH, MDA levels 
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                                  Protein levels of catalase, TNF-α, IL-6, cyclin D1, cyclin D3,  
                                  cyclin E, cyclin A, cdk4, cdk2 
 
Fig 1.5 Summary of study. After induction of cirrhosis using thioacetamide, the rats 
were subjected to 70% PH. The excised livers were collected. At 3, 6, 24, 48, 72 hours 
post hepatectomy, the remnant livers were also collected. Liver homogenate as well as 
the mitochondrial and cytosolic fractions and total RNA were prepared. The RNA was 
used to measure the expression of 28S rRNA, HGF, TGF-α, p21, p27, p53 by RT-PCR. 
Intact mitochondria were used to measure the RCR, the P/O ratio and the state 3 and state 
4 respiration, while submitochondrial particles were used to assay the activities of 
ATPase, SCCR, NCCR, CCO, GPx, GRd and protein expression of catalase. The levels 
of GSH and MDA were also determined. The liver homogenate was used to determine 
the total hepatic GSH concentration, while the cytosolic fraction was used to determine 
the activities of GPx, GRd or protein levels of catalase, TNF-α, IL-6, cyclin D1, cyclin 




Materials and methods 
 
2.1 Chemicals 
Sucrose, Bio-Rad protein assay dye, N, N, N’, N’-tetra-methylethylenediamine, 
ammonium persulfate, prestained SDS-PAGE Standards Broad Range and ethidium 
bromide were obtained from Bio-Rad (Hercules, CA, USA). Glutathione was from ICN 
(Aurora, Ohio, USA). Tris-(hydroxymethyl) aminomethane was from J.B.Baker 
(Phillipsburg, NJ, USA). Sodium dithionite, sodium dihydrogen phosphate, disodium 
hydrogen phosphate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, 
hydrochloric acid, sulfuric acid, sodium chloride and chloroform were purchased from 
Merck (Darmstadt, Germany). Monochlorobimane (MCB) was purchased from 
Molecular Probes (Eugene, OR, USA). Mouse monoclonal antibodies against cyclin D1 
(72-13G) and cdk2 (M2), rabbit polyclonal antibodies against cyclin A (C-19), cyclin D3 
(C-16), cyclin E (M-20), cdk4 (H-303) were from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA). Tween 20 was from Duchefa (Haarlem, Netherlands). Enhanced 
chemiluminescence western blotting detection kit, high performance film and 
nitrocellulose membrane were from Amersham Biosciences (Little Chalfont, 
Buckinghamshire, England). TRIZOL Reagent was from GIBCO BRL. Access RT-PCR 
System was from Promega (Madison, WI, USA). Rat TNF-α and IL-6 ELISA kits were 
from Bender MedSystems (Vienna, Austria). MOPS running buffer was from Ambion 
(Austin, TX, USA). Rabbit polyclonal anti-actin, acrylamide, N, N’-methylene-bis-
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acrylamide, glycine, lauryl sulfate and 2-mercaptoethanol, isopropyl alcohol, RNA 
loading buffer, mineral oil and other chemicals were purchased from Sigma (St. Louis, 
MO, USA). 
 
2.2 Induction of cirrhosis 
Ten-week old male Wistar-Furth rats were kept on standard rat chow and tap water ad 
libitum under 12 hr light-dark cycles. Cirrhosis was induced by intraperitoneal injection 
of 300 mg thioacetamide/kg thrice weekly for 10 weeks as previously described with 
slight modifications (Chijiiwa K et al, 1994 and Zhao G et al, 2002). Healthy, control 
animals were kept under the same conditions without any treatment. All animals received 
humane care in compliance with the International Guiding Principles for Animal 
Research adapted from WHO Chronicle (1985), 39(2): 51-56. After one week 
acclimation to allow for the washout of thioacetamide, all animals underwent 70% PH. 
Two experimental groups were studied. In Group 1, healthy, control rats were submitted 
to PH while in Group 2, cirrhotic animals were submitted to PH. Within each group, six 
rats were sacrificed at 3, 6, 24, 48 and 72 hours after surgery. 
 
2.3 Partial hepatectomy 
The rats were anesthetized by an intraperitoneal injection of ketamine (60 mg/kg) 
followed by ether inhalation. Through a midline incision, a 70% hepatectomy was 
performed by removing the median and left lateral lobes of the liver as described by 
Higgins and Anderson (Higgins G et al, 1931). The wound was closed with catgut suture 
and the rats recovered. At 3, 6, 24, 48 and 72 hours after surgery, the rats were 
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anesthetized with ether and killed by exsanguination after the drawing of blood from the 
heart. The remnant livers were then removed and a part of the left lateral lobe was used 
for histological examination. Cirrhosis was confirmed by gross inspection and 
histological examination. 
 
2.4 Preparation of mitochondria 
Mitochondria were prepared from the excised and the remaining resected liver as 
previously described with slight modifications (Johnson D et al, 1967). The liver was 
chopped into small pieces and homogenized in 5 volumes of buffer containing 0.25 M 
sucrose, 5 mM HEPES and 0.5 mM EGTA, pH 7.5. The homogenate was centrifuged at 
585 g at 4 °C for 10 minutes. This was repeated twice and 2 ml of the supernatant was 
stored at -80 °C and used for determination of hepatic glutathione (GSH). The remaining 
was centrifuged at 12 100 g at 4 °C for 10 minutes. The pellet was washed twice with 
buffer containing 0.25 M sucrose and 5 mM HEPES, pH 7.5. The mitochondria pellet 
was then resuspended and the protein concentration was determined with the Bio-Rad 
protein assay dye reagent using bovine serum albumin as the standard. Freshly prepared 
mitochondria were used for the determination of respiratory control and ADP/O ratios 
while submitochondrial particles were used for all other assays. Submitochondrial 
particles were prepared by freezing and thawing the mitochondrial suspension. 
 
2.5 Measurement of protein concentration 
The Bio-Rad Protein Assay is based on the method of Bradford. The absorbance 
maximum for an acidic solution of Coomassie Brilliant Blue G-250 dye shifts from 465 
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nm to 595 nm when bound to protein. The Coomassie blue dye binds primarily to basic 
and aromatic amino acid residues, especially arginine.  
 
0.1, 0.3, 0.5, 0.7 and 0.9 mg/ml BSA standards were prepared. 1 part Bio-Rad Protein 
Assay Dye Reagent Concentrate was diluted with 4 parts distilled, deinonized (DDI) 
water and filtered through Whatman #1 filter to remove particulates. 1 ml diluted dye was 
added to 20 μl standard or sample, mixed and incubated at room temperature for at least 5 
minutes but less than 1 hour. The absorbance was measured at 595 nm.  
 
2.6 Determination of the respiratory control and ADP/O ratios 
This was determined polarographically using a Clark oxygen electrode (Hansatech, 
Pentney, Norfolk, England) (Estabrook R, 1967). Mitochondria suspension containing 2.5 
mg protein was added to 2 ml of buffer containing 0.1 M KCl, 10 mM Tris-Cl, 12.5 mM 
KH2PO4 and 12.5 mM potassium succinate, pH 7.6. Oxygen consumption was measured 
in the absence (giving the state 4 activity) as well as in the presence of 0.25 mM ADP 
(giving the state 3 activity). The respiratory control ratio (RCR) was expressed as the 
ratio of state 3 respiration to that of state 4, while the ADP/O ratio was expressed as the 
ratio of ADP added to that of oxygen atoms consumed during state 3 respiration. 
 
2.7 Mitochondrial NADH-cytochrome c reductase activity  
NADH-cytochrome c reductase (NCCR) activity was measured as previously described 
(Boffoli D et al, 1994). 5 μg of submitochondrial particles was added to 1 ml of buffer 
containing 25 mM potassium phosphate, pH 7.4, 2.5 mg/ml bovine serum albumin, 5 mM 
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MgCl2, 10 μM ferricytochrome c and 2 mM KCN. The reaction was started by the 
addition of 25 μM NADH. Reduction of ferricytochrome c was followed at 25 oC at 550 
nm for 3 min. The extinction coefficient of cytochrome c is 19 mM-1cm-1 (Tsai J et al, 
1992). 
 
2.8 Mitochondrial succinate-cytochrome c reductase activity  
Succinate-cytochrome c reductase (SCCR) activity was measured as previously described 
(Boffoli D et al, 1994). 5 μg of submitochondrial particles was added to 1 ml of 50 mM 
potassium phosphate, pH 7.4, 20 mM succinate, 10 μM ferricytochrome c, 2 μg/ml 
rotenone and 2 mM KCN at room temperature. The absorbance change at 550 nm was 
recorded at 25 oC for 5 min. The extinction coefficient of cytochrome c is 19 mM-1cm-1     
(Tsai J et al, 1992). 
 
2.9 Mitochondrial cytochrome c oxidase activity  
Cytochrome c oxidase (CCO) activity was measured as previously described (Boffoli D 
et al, 1994). 5 μg of submitochondrial particles was added to 1 ml of 50 mM potassium 
phosphate, pH 7.4 and 10 μM ferrocytochrome c (reduced by sodium dithionite at a 
weight ratio of 2:7, the solution was then shaken vigorously for 2 minutes to remove 
excess sodium dithionite). The absorbance change at 550 nm was recorded at 25 oC for 5 




2.10 Mitochondrial ATPase activity  
This was determined by measuring the release of inorganic phosphate (Penney C et al, 
1978). The reaction was initiated by addition of 250 μg of submitochondrial particles to 
0.25 ml of buffer containing 1 mM ATP, 100 mM NaCl, 10 mM KCl and 3 mM MgCl2, 
pH 7.4. After incubation at 37°C for 5 minutes, the reaction was stopped by addition of 2 
ml of 0.1 M ice-cold HCl. 0.2 ml of the reacted mixture or standards corresponding to 0, 
0.02, 0.04, 0.06, 0.08 and 0.1mM KH2PO4 were added to 0.8 ml of 5 mM H2SO4. 160 μl 
of 2.5% ammonium molybdate and 40 μl of 1% stannous chloride were then added. After 
incubation at 25 oC for 15 min, the absorbance at 680 nm was read. 
 
2.11 Hepatic and mitochondrial glutathione determination 
Glutathione (GSH) levels were measured by using the specific reaction of MCB with 
GSH. MCB, itself nonfluorescent, forms a stable, fluorescent adduct, bimane-GS with 
GSH in a reaction catalyzed by GSH S-transferases (GST) (Fernandez-Checa et al, 1990).  
 
The endogenous GST was first removed by boiling the sample for 3 min. To quantify the 
amount of GSH, 0.2 U of equine liver GST was added to 250 μl of phosphate-buffered 
saline, 0.1 mM MCB and GSH standards corresponding to 0-0.04 mM GSH or to the 
sample. Following incubation at 37ºC for 15 min, the fluorescence of all samples was 
read using an excitation wavelength of 385 nm and an emission wavelength of 478 nm in 
a Gemini XS microplate spectrofluorometer from Molecular Devices Corp., USA.  
Following this, a calibration curve was obtained and the fluorescence of the samples was 
then correlated with the curve. 
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 2.12 Mitochondrial and cytosolic superoxide dismutase activity  
This was measured using the method of Flohe and Otting (Flohe L et al, 1984). 1.45 ml 
of solution A (containing 0.76 mg xanthine dissolved in 10 ml 0.001 N NaOH and 24.8 
mg cytochrome c were mixed with 100 ml 50 mM KH2PO4-Na2HPO4, 0.1 mM EDTA, 
pH 7.8) was pipetted into a cuvette. The suspension of submitochondrial particles was 
spun and 25 μl of the supernatant (0.5 mg protein) was added to solution A. The reaction 
was started by addition of 25 μl of solution B (freshly prepared xanthine oxidase in 0.1 
mM EDTA to produce a rate of cytochrome c reduction of 0.025 absorbance units/min in 
the control without SOD). The absorbance change at 550 nm was recorded at 25 oC for 5 
min.  
 
To assay for the cytosolic SOD activity, cytosol (50 μg protein) was used in place of the 
sub-mitochondrial particles.  
 
2.13 Mitochondrial and cytosolic glutathione peroxidase activity 
This was measured using the method of Flohe and Gunzler (Flohe L et al, 1984). The 
following solutions were pipetted into a cuvette: 500 μl of buffer containing 0.1 M 
potassium phosphate / 1 mM EDTA, pH 7.0, 100 μl submitochondrial particles (50 μg 
protein), 100 μl (0.24 U) glutathione reductase (freshly prepared in 0.1 M potassium 
phosphate / 1 mM EDTA, pH 7.0) and 100 μl of 10 mM GSH. The mixture was 
preincubated for 10 min at 25 oC. 100 μl 1.5 mM NADPH in 0.1% NaHCO3 was then 
added. The reaction was started by adding 100 μl of 12 mM t-butyl hydroperoxide. The 
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decrease in absorption at 340 nm was monitored for 5 min. The extinction coefficient of 
NADPH is 6.2 mM-1cm-1. 
 
To assay for the cytosolic glutathione peroxidase activity, cytosol (20 μg protein) was 
used in place of the sub-mitochondrial particles.  
 
2.14 Mitochondrial and cytosolic glutathione reductase activity  
This was measured as previously described (Racker E, 1955). Submitochondrial particles 
(150 μg protein) were added to 1 ml of 50 mM potassium phosphate, pH 7.6, 0.1 mM 
NADPH, 1 mg bovine serum albumin and 3.25 mM oxidized glutathione. The oxidation 
of NADPH was monitored at 340 nm at 25 oC for 5 min in a spectrophotometer. The 
extinction coefficient of NADPH is 6.2 mM-1cm-1. 
 
To assay for the cytosolic glutathione reductase activity, cytosol (50 μg protein) was used 
in place of the sub-mitochondrial particles.  
 
2.15 Measurement of malondialdehyde 
The extent of lipid peroxidation was determined by the thiobarbituric acid (TBA) test 
(Ohkawa H et al, 1979). 50 μl of 8.1% SDS, 375 μl of 20% acetic acid solution (adjusted 
to pH 3.5 with NaOH) and 375 μl of 0.6% aqueous solution of TBA were added to 200 μl 
of 0.4 mg/ml mitochondria suspension. The mixture was heated in a water bath at 95 °C 
for 60 min. After cooling, 1 ml of mixture of n-butanol and pyridine (15:1, v / v) was 
added and mixed vigorously. After centrifugation at 4 000 g for 10 min, the organic layer 
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was taken and its absorbance at 532 nm was measured. Results were expressed in 
malondialdehyde equivalents using 1, 1, 3, 3, - tetraethoxypropane as the standard. 
 
2.16 Western blotting 
ELECTROPHORESIS AND BLOTTING 
The 12 % resolving gel (11.68% acrylamide, 0.32% N, N’-methylene-bis-acrylamide, 
0.375 M Tis-HCL, pH 8.8, 0.1% SDS, 0.05% APS, 0.005% TEMED) was first cast. The 
monomer solution was then overlaid with water and the gel was allowed to polymerize 
for 45 minutes to 1 hour. The water was then removed and the 3% stacking gel (2.92% 
acrylamide, 0.08% N, N’-methylene-bis-acrylamide, 0.125 M Tris-HCl, pH 6.8, 0.1% 
SDS, 0.05% APS, 0.01% TEMED) was cast and the gel was allowed to polymerize for 
30-45 minutes. The wells were rinsed thoroughly with distilled water before use.  
 
Equal amounts of cytosolic protein from 6 different animals in each group were pooled 
per each sample point. 25 μg protein of each pooled sample was diluted at least 1:2 with 
sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol 
blue, 5% β-mercaptoethanol). The samples were loaded into the wells of the 12% SDS-
polyacrylamide gel. The gel was run in running buffer (25 mM Tris, 192 mM glycine, 
0.1% SDS) at 200V for 50 minutes. The gel and nitrocellulose membrane were then pre-
equilibrated in transfer buffer (25 mM Tris, 192 mM glycine) for 40 minutes and the 





Non-specific binding sites were blocked by immersing the membrane in 5% non-fat milk, 
0.1% (v/v) Tween 20 in Tris buffered saline, TBS-T (50 mM Tris-HCl, 150 mM NaCl, 
pH 7.5) overnight at 4°C.  
 
PRIMARY ANTIBODY INCUBATION 
Anti-cyclin D1 was diluted 1:100 with 1% non-fat dried milk, TBS-T. Anti-cyclin A, 
anti-cyclin D3, anti-cyclin E, anti-CDK2 and anti-CDK4 were diluted 1:200. To check 
the equal loading of the gels, western blots using anti-actin were performed. Anti-actin 
was diluted 1:2500. The membrane was incubated in diluted primary antibody for 1 hour 
at room temperature on an orbital shaker and washed 3 times for 10 minutes each with 
TBS-T.  
 
SECONDARY ANTIBODY INCUBATION 
Horseradish peroxidase labeled anti-mouse or anti-rabbit IgG was diluted 1:5000 with 
1% non-fat dried milk, TBS-T. The membrane was incubated in diluted secondary 
antibody for 1 hour at room temperature on an orbital shaker and washed 3 times for 10 
minutes each with TBS-T.  
 
DETECTION 
An equal volume of detection solution 1 was mixed with detection solution 2. The excess 
wash buffer was drained from the washed membrane by holding the membrane gently 
with forceps and touching the edge against a tissue. The membrane was placed protein 
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side up. The mixed detection reagent was pipetted on to the membrane and incubated for 
1 minute at room temperature. Excess detection reagent was drained off. The membrane 
was placed protein side down on to a piece of SaranWrap. The membrane was wrapped 
and air bubbles were gently smoothed out. The wrapped membrane was placed protein 
side up in an X-ray film cassette. A film was placed on top of the membrane. The cassette 
was closed. The film was exposed for 5 seconds to 5 minutes and developed.  
 
QUANTIFICATION 
The film was scanned. The bands were quantified with Analytical Imaging Station 
software (Imaging Research, St. Catharines, Antaro, Canada). 
 
2.17 ELISA 
2.17.1 TNF-α ELISA  
The microwell strips were washed twice with approximately 300 μl wash buffer per well. 
After each wash, wells were emptied and microwell strips were tapped on paper towel to 
remove excess wash buffer.  
 
100 μl of sample diluent was added in duplicate to all standard wells. 100 μl of 
reconstituted rat TNF-α standard was pipetted in duplicate into the first sets of wells and 
standard dilutions ranging from 2500 to 39 pg/ml were created by transferring 100 μl 
from well to well. 100 μl of contents were discarded from the last microwells, and 100 μl 
of sample diluent was added in duplicate to the blank wells.  
 
 54
50 μl of sample diluent was added to the sample wells, and 50 μl of each sample was 
added in triplicate to the designated wells.  
 
The biotin-conjugate was then prepared and 50 μl was added to all wells. The wells were 
covered with a plate cover and incubated at room temperature for 2 hours. The plate 
cover was removed and the wells were emptied. The microwell strips were washed 4 
times.  
 
The streptavidin-HRP was prepared and 100 μl was added to all wells. The wells were 
covered with a plate cover and incubated at room temperature for 1 hour. The plate cover 
was removed and the wells were emptied. The microwell strips were washed 4 times.  
 
TMB substrate solution was prepared and 100 μl was added to all wells. The microwell 
strips were incubated at room temperature for about 15 minutes. The enzyme reaction 
was stopped by quickly pipetting 100 μl of stop solution into each well. The absorbance 
of each microwell was read on a spectro-photometer using 450 nm as the primary 
detection wave length and 650 nm as the reference wave length.  
 
2.17.2 IL-6 ELISA 
The procedure was similar to that for the TNF-α ELISA except: 
100 μl of assay buffer was added in duplicate to all standard wells. 100 μl of reconstituted 
rat IL-6 standard was pipetted in duplicate into the first wells and standard dilutions 
ranging from 2000 to 31.3 pg/ml were created by transferring 100 μl from well to well. 
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100 μl of contents were discarded from the last microwells. 100 μl of assay buffer was 
added in duplicate to the blank wells.  
 
50 μl of assay buffer was added to the sample wells, and 50 μl of each sample was added 
in triplicate to the designated wells.  
 
2.18 mRNA analysis 
2.18.1 RNA ISOLATION 
HOMOGENIZATION 
50-100 mg of liver was homogenized in 1 ml of TRIZOL Reagent per 50-100 mg of liver 
using a hand-held homogenizer.  
 
PHASE SEPARATION 
0.4 ml of chloroform was added for each ml of TRIZOL Reagent. The sample was mixed 
by vortexing and left at room temperature for 2 to 3 minutes. The samples were 
centrifuged at 10,000 g for 15 minutes at 4°C.  
 
RNA PRECIPITATION 
The RNA was precipitated from the aqueous phase by mixing with isopropyl alcohol. 1 
ml of isopropyl alcohol was added per 1 ml of TRIZOL Reagent used for the initial 
homogenization. The samples were incubated at room temperature for 10 minutes and 




The supernatant was removed and the RNA pellet was washed with 75% ethanol. 1 ml of 
75% ethanol was added per 1 ml of TRIZOL Reagent used for the initial homogenization. 
The sample was mixed by vortexing and centrifuged at 7,500 g for 5 minutes at 4°C. 
 
REDISSOLVING THE RNA 
The RNA pellet was vacuum-dried for 1 minute and dissolved in RNase-free water. 
 
CONCENTRATION AND QUALITY OF THE RNA 
RNA concentration was measure in a spectrophotometer at 260 nm and 280nm. The 
260/280 ratio should be more than 1.6. Protein contamination is reflected by low 260/280 
ratio. The RNA quality was also checked by running the 1.2% agarose gel to rule out 
degradation of the RNA and DNA contamination.  
 
1.2% agarose gel (1X MOPS, 0.369M formaldehyde, DEPC treated H2O) was cast. The 
gel was pre-run in 1X MOPS running buffer at 80V for 10 minutes. 2 μg of RNA was 
mixed with 2 volumes of RNA loading buffer containing 0.5 μg/ml ethidium bromide and 
incubated at 65 °C for 10 minutes before loaded into the gel. The gel was run at 80V for 
50 minutes. The intact 18S and 28S rRNA bands were visualized under UV light.  
 
2.18.2 RT-PCR 
The reaction mix was prepared by combining the indicated volumes of Nuclease-Free 
Water, AMV/Tfl 5X Reaction Buffer, dNTP Mix, the specific upstream and downstream 
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primers, and 25 mM MgSO4 in a thin-walled 0.5 ml reaction tube on ice. The components 
were mixed by pipetting. The AMV Reverse Transcriptase and Tfl DNA Polymerase 
were added to the reaction. The tube was gently vortexed for 10 seconds to mix the 
components. The reaction was initiated by adding 0.8 μg RNA sample.  
 
                                                                                         Volume          Final Concentration                             
Nuclease-Free Water (to a final volume of 50 μl)               31 μl               
AMV/Tfl 5X Reaction Buffer                                              10 μl                                     1X 
dNTP Mix (10 mM each dNTP)                                            1 μl                             0.2 mM 
Downstream primer                                                         50 pmol                                1 μM 
Upstream primer                                                              50 pmol                                1 μM 
AMV Reverse Transcriptase (5 u/μl)                                     1 μl                             0.1 u/μl 
Tfl DNA Polymerase (5 u/μl)                                                 1 μl                             0.1 u/μl 
RNA sample                                                                           4 μl     
Final volume                                                                         50 μl   
 
The reaction was overlaid with one drop of nuclease-free mineral oil to prevent 
evaporation. The tubes were placed in an eppendorf Mastercycler gradient (Hamburg, 
Germany) and incubated for 45 minutes at 48°C. The reaction mix was then allowed to   





First Strand cDNA synthesis 
 
1 cycle                        48°C for 45 minutes                       reverse transcription 
1 cycle                        94°C for 2 minutes                        AMV RT inactivation and  
                                                                                           RNA/cDNA/primer denaturation 
 
Second Strand cDNA Synthesis and PCR Amplification (25-40 cycles) 
                                    94°C for 30 seconds                      denaturation 
                                    60°C for 1 minute                          annealing 
                                    68°C for 2 minutes                        extension 
1 cycle                        68°C for 7 minutes                         final extension 
1 cycle                        4°C                                                 soak 
 
The PCR reaction products were analyzed by 1% agarose gel electrophoresis in 1X TAE 
buffer and the DNA bands were visualized under UV light. 
Primers used to amplify the mRNA are shown in Table 2.1. 
 
2.19 Statistical analysis 
Data were expressed as means + SEM and were subjected to ANOVA analysis followed 
by a Tukey post-hoc test. A p-value of less than 0.05 was considered significant. Two 
sets of comparisons were carried out. The first was within Group 1 for the healthy 
controls before and post-PH. The second comparison was between Group 1 and Group 2 













Table 2.1 Primers for reverse-transcription-PCR of HGF, TGF-α, p21, p27 and p53 








Sequence (5’- 3’) 
28S 28S Forward 
28S Reverse 
GGC CAA GCG TTC ATA GCG AC 
GAG GCG TTC AGT CAT AAT CC 
 
HGF HGF Forward 
HGF Reverse 
CCC GGT GCT GCA GCA TGT CCT 
TCC CCT CGA TTT CGA CAG  
 
TGF-α TGF-α Forward 
TGF-α Reverse 
GAC AAG TTG AAC AAG AAC CTC 
CGT CAT CCA CCT AAT ACA TAA G 
 
p21 p21 Forward 
p21 Reverse 
ATG TCC GAT CCT GGT GAT GTC 
CAC TTC AGG GCT TTC TCT TGC 
 
p27 p27 Forward 
p27 Reverse 
GCA GCT TGC CCG AGT TCT AC 
TTC TTG GGC GTC TGC TCC AC 
 
p53 p53 Forward 
p53 Reverse 
TCC TCC CCA ACA TCT TAT CC 
GCA CAA ACA CGA ACC TCA AA 
 
                           
 
#The 28S primers were kindly provided by Assoc. Prof. Chang Chan Fong (Department 
of Biochemistry, National University of Singapore). The primers for HGF, TGF-α, p21, 
p27 and p53 were as previously reported (Masson S et al, 1999; Mitsui S et al, 2001; 
Higami Y et al, 2000).  
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Chapter 3  
Induction of cirrhosis 
 
3.1 Introduction 
A diseased liver can become increasingly fibrotic and eventually cirrhotic. Cirrhotic 
livers have an increased risk of developing hepatocellular carcinoma. Hepatocellular 
carcinoma is the third most common cause of death due to cancer worldwide (Parkin DM 
et al, 2001). To study cirrhosis, various experimental models have been developed. These 
include thioacetamide, carbon tetrachloride, alcohol or bile duct ligation induced cirrhosis 
in rats.  
 
The thioacetamide-induced rodent model of liver cirrhosis was employed as induction of 
cirrhosis with thioacetamide is highly reproducible, irreversible and produces 
morphological features similar to that observed in human cirrhosis (Li X et al, 2002). 
Thus, in this study, cirrhosis was induced in male Wistar-Furth rats by regular injections 
of thioacetamide. Both 200 mg/kg (Sanz N et al, 1995) and 300 mg/kg doses (Chijiiwa K 
et al, 1994) have been used to induce liver cirrhosis in rats. In this part of the study, both 






3.2 Thioacetamide induced liver cirrhosis  
Liver cirrhosis was induced by injection of 300 mg/kg thioacetamide as described in 
section 2.2. Fig 3.1A-B show the normal liver and thioacetamide induced cirrhotic liver 
in Wistar Furth rats. By intraperitoneal injection of thioacetamide thrice weekly, the rats 
developed progressive hepatic fibrosis culminating in gross cirrhosis after 10 weeks of 
treatment (Low et al, 2004). Cirrhosis was confirmed by gross inspection and histological 
examination (by Professor A. Wee, Department of Pathology, National University of 
Singapore). Liver cirrhosis was similarly induced by injection of 200 mg/kg 
thioacetamide. 
 
3.3 Effects on mitochondrial function and GSH levels 
There were no significant differences in state 3 respiration, state 4 respiration, the 
respiratory control, the ADP/O ratios, ATPase activities and hepatic GSH levels between 
rats treated with 300 mg/kg and 200 mg/kg thioacetamide. At each dosage, there were no 
significant differences between cirrhotic and normal rats, either (Table 3.1). Thus, the 
300 mg/kg induction protocol was used for subsequent experiments.  
 
3.4 Conclusions 
After injection of 300 mg/kg thioacetamide thrice weekly for 10 weeks, the rats 
developed liver cirrhosis. The mitochondrial function and hepatic GSH level were not 
significantly different from those of the 200 mg/kg thioacetamide treated animals and 
controls. The 300 mg/kg dose was thus used for all subsequent experiments.  
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Table 3.1 Comparison of mitochondrial function and hepatic GSH level in normal 





300 mg/kg  
Normal 






n = 30 
 
Cirrhotic 
n = 30 
State 3 (nmol O/min/mg 
protein) 
94.0+4.4 114.8+4.6 116.6+5.1 113.4+5.0 
State 4 (nmol O/min/mg 
protein) 
19.8+2.0 25.2+0.4 23.9+1.1 29.0+0.8 
Respiratory control ratio 
 
4.6+0.2 4.5+0.3 4.4+0.1 4.0+0.2 
ADP/O 
 
2.1+0.2 2.2+0.2 1.9+0.1 1.9+0.1 
ATPase activity 
(nmol/min/mg protein) 
65.0+1.8 69.7+4.0 62.2+1.6 66.5+1.6 
NCCR activity 
(nmol/min/mg protein) 
N. D. N. D. 673.4 + 27.5 427.8+23.5* 
SCCR activity 
(nmol/min/mg protein) 
N. D. N. D. 104.3 + 6.3 88.1 + 5.5 
CCO activity (nmol/min/mg 
protein) 
N. D. N. D. 130.2 + 5.3 174.2 + 7.7 
Hepatic GSH (nmol/mg 
protein) 
81.4+3.7 98.3+5.4 82.0+2.8 98.8+2.7 
 
 
Data are presented as mean + S.E.M. State 3 respiration, state 4 respiration, respiratory 
control ratio and ADP/O ratio were determined in the presence of succinate. 
Submitochondrial particles were used to determine the mitochondrial ATPase, NADH-
cytochrome c reductase (NCCR), succinate-cytochrome c reductase (SCCR) and 
cytochrome c oxidase (CCO) activities. Liver homogenates were used to determine the 
hepatic GSH level. *Compared with normal group, p<0.05 and is statistically different, 










































For many liver malignancies including hepatocellular carcinoma, major hepatectomy is 
the main course of therapy. Although a normal liver has a tremendous capacity for 
regeneration, liver hepatectomy in humans is usually carried out on a diseased liver and 
in such instances, liver regeneration takes place in a cirrhotic remnant.  
 
The regenerative process itself places a high energy demand on the hepatocytes 
(Kamiyama Y et al, 1976; Inomoto T et al, 1994; Guerrieri F et al, 1995 and Mann D et 
al, 2001). The energy required is supplied by the mitochondria through the process of 
oxidative phosphorylation. Animal studies on mitochondrial function in the normal liver 
following PH have been performed. During the regeneration process, increases in 
respiratory control and phosphorylation rates together with changes in activities of the 
complexes involved in the electron-transport chain have been observed (Kamiyama Y et 
al, 1976; Inomoto T et al, 1994; Tsai J et al, 1992; Satoh S et al, 1996 and Hernandez-
Munoz R et al, 2003). 
 
Fibrotic or cirrhotic livers do not tolerate insults well and experience delayed 
regeneration following surgery. Several studies using whole cirrhotic rat livers have 
demonstrated that cirrhotic livers have an impaired capacity to carry out oxidative 
phosphorylation (Moller B et al, 1984 and Krahenbuhl S et al, 1989). We postulate that 
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this may in turn have an adverse effect on liver regeneration after hepatectomy leading to 
inadequate responses to increased energy demand. To verify this, liver cirrhosis was 
induced by thioacetamide administration to rats and the changes in mitochondrial 



















4.2 Respiratory enzymes activities in normal and cirrhotic livers 
The animals were divided into 2 experimental groups. Group 1 consisted of 30 healthy, 
control rats, while group 2 consisted of 30 cirrhotic rats (following administration of 300 
mg thioacetamide / kg, thrice weekly for 10 weeks). Liver mitochondria were isolated 
from control and cirrhotic rats as described in section 2.4. Respiratory control and 
ADP/O ratios were analyzed as described in section 2.6. Using succinate as the substrate, 
there were no differences in state 3 respiration, state 4 respiration, the respiratory control 
and the ADP/O ratios between the two groups of animals. Submitochondrial particles 
were used to determine the mitochondrial ATPase, NADH-cytochrome c reductase 
(NCCR), succinate-cytochrome c reductase (SCCR) and cytochrome c oxidase (CCO) 
activities. NCCR, SCCR, CCO and ATPase activities were analyzed as described in 
section 2.7, 2.8, 2.9 and 2.10 respectively. There were no significant differences in the 
SCCR, CCO and ATPase activities. However, NCCR activity was significantly lowered 










4.3 Changes in mitochondrial respiratory enzymes and ATPase 
following hepatectomy 
PH was performed as described in section 2.3. To examine how PH influences 
mitochondrial respiratory activity, liver mitochondria were isolated at various time points 
post-PH. At each time point, mitochondria were isolated from six cirrhotic rats and six 
control rats. Mitochondria from each animal were assayed individually to determine 
activities related to the respiratory chain and oxidative phosphorylation. Activities from 
the excised livers of control rats were used as the basis for comparison and set at 100%. 
Comparison was carried out firstly to determine if there were significant changes in 
controls (Group 1 rats) following PH and secondly to determine if there were significant 
differences between the control (Group 1) rats and the cirrhotic (Group 2) rats during the 
entire course of the experiment. 
 
 
4.3.1 SCCR activity 
In control rats, there was no change in the SCCR activity following PH. However, the 
SCCR activity in cirrhotic livers was lowered at 6 h till 72 h post-PH, although statistical 
significance was only observed at 48 h (Fig 4.1A). 
 
4.3.2 NCCR activity 
Mitochondria isolated from control rats showed no changes in NCCR activity following 
PH. However, the NCCR activity at all time points was significantly reduced in 

































Fig 4.1A Time-dependent changes of succinate-cytochrome c reductase (SCCR) 
activities from control (solid line) and cirrhotic rats (broken lines) after partial 
hepatectomy. Results (mean + S.E.M. from six rats in each group) are expressed as 
percent of control activity at 0h (100%). Control value for SCCR was 104.3 + 6.3 
nmol/min/mg mitochondrial protein and was determined from the excised livers (at 0h) of 
all control rats (n=30) used in the study. #p<0.05, ANOVA analysis, for comparison 















































Fig 4.1B Time-dependent changes of NADH-cytochrome c reductase (NCCR) 
activities from control (solid line) and cirrhotic rats (broken lines) after partial 
hepatectomy. Results (mean + S.E.M. from six rats in each group) are expressed as 
percent of control activity at 0h (100%). Control value for NCCR 673.4 + 27.5 
nmol/min/mg mitochondrial protein and was determined from the excised livers (at 0h) of 
all control rats (n=30) used in the study. #p<0.05, ANOVA analysis, for comparison 













4.3.3 CCO activity 
In control animals, the CCO activity was significantly increased at 24 h up till 72 h post-
PH. During the entire course of the study, the CCO activity in mitochondria from 
cirrhotic animals was not significantly different from that of the control group (Fig 4.1C). 
 
4.3.4 Respiratory control and P/O ratios 
Respiration using succinate was also examined with intact mitochondria. Six hours after 
PH, state 3 and state 4 respiration were reduced to 65% + 7 % and 65% + 3% 
respectively in the control group while the RCR was significantly increased at 24 h post-
PH (Fig 4.2A-C).  
 
In contrast, for the cirrhotic rats, the RCRs were significantly lower when compared to 
the corresponding controls at 6 h till 48 h post-PH (Fig 4.2C). This concurs with the 
lower SCCR activities over the same time points. The ADP/O ratios were not affected 
except at 6-hr when the ratio for the cirrhotic group was significantly lowered when 
compared to the corresponding controls (Fig 4.2D). 
 
4.3.5 Mitochondrial ATPase activity 
The activity of the mitochondrial F0F1 ATPase was also assayed. Increased ATPase 
activity at 3 h and 6 h post-PH was observed in mitochondria from cirrhotic rats when 








































Fig 4.1C Time-dependent changes of cytochrome c oxidase (CCO) activities from 
control (solid line) and cirrhotic rats (broken lines) after partial hepatectomy. 
Results (mean + S.E.M. from six rats in each group) are expressed as percent of control 
activity at 0h (100%). Control value for CCO were 130.2 + 5.3 nmol/min/mg 
mitochondrial protein and was determined from the excised livers (at 0h) of all control 
rats (n=30) used in the study. *p<0.05, ANOVA analysis, for comparison between control 



































Fig 4.2A Changes in liver mitochondrial state 3 respiration of control (solid line) 
and cirrhotic rats (broken lines) following partial hepatectomy. State 3 respiration, 
was measured using succinate as the substrate. Results (mean + S.E.M. from six rats in 
each group) are expressed as percent of control activity at 0h (100%). Control value for 
state 3 was 116.6 + 5.1 nmol O atom/min/mg mitochondrial protein and was determined 
from the excised livers (at 0h) of all control rats (n=30) used in the study. *p<0.05, 






































Fig 4.2B Changes in liver mitochondrial state 4 respiration of control (solid line) and 
cirrhotic rats (broken lines) following partial hepatectomy. State 4 respiration was 
measured using succinate as the substrate. Results (mean + S.E.M. from six rats in each 
group) are expressed as percent of control activity at 0h (100%). Control value state 4 
was 23.9 + 1.1 nmol O atom/min/mg mitochondrial protein and was determined from the 
excised livers (at 0h) of all control rats (n=30) used in the study. *p<0.05, ANOVA 





































Fig 4.2C Changes in liver mitochondrial respiratory control ratio (RCR) of control 
(solid line) and cirrhotic rats (broken lines) following partial hepatectomy. 
Respiratory control ratio (RCR) was measured using succinate as the substrate. Results 
(mean + S.E.M. from six rats in each group) are expressed as percent of control activity 
at 0h (100%). Control value for RCR and ADP/O ratio was 4.4 + 0.1 and was determined 
from the excised livers (at 0h) of all control rats (n=30) used in the study. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 

































Fig 4.2D Changes in liver mitochondrial ADP/O ratio of control (solid line) and 
cirrhotic rats (broken lines) following partial hepatectomy. ADP/O ratio was 
measured using succinate as the substrate. Results (mean + S.E.M. from six rats in each 
group) are expressed as percent of control activity at 0h (100%). Control value for 
ADP/O ratio was 1.9 + 0.1 and was determined from the excised livers (at 0h) of all 
control rats (n=30) used in the study. #p<0.05, ANOVA analysis, for comparison between 












































Fig 4.3 Mitochondrial ATPase activities from control (solid line) and cirrhotic rats 
(broken lines) after partial hepatectomy. Results (mean + S.E.M. from six rats in each 
group) are expressed as percent of control activity at 0h (100%). The control activity was 
62.2 + 1.6 nmol/min/mg mitochondrial protein and was determined from the excised 
livers (at 0h) of all control rats (n=30) used in the study. #p<0.05, ANOVA analysis, for 










Compared to the controls, cirrhotic livers have diminished oxidative phosphorylation 
capabilities due to changes in NADH-linked and FADH2-linked respiration following 
PH. The diminished ATP production, if critical, would then impede the liver regeneration 
process resulting in liver failure. Indeed, diminished ATP production had been observed 
not only in rodent experimental models (Morimoto T et al, 1992 and Kurokawa T et al, 




































In aerobic organisms, energy is supplied by the mitochondria through the process of 
oxidative phosphorylation, whereby the ultimate electron accepter is oxygen. Thus, 
reactive oxygen species are often formed as byproducts of mitochondrial oxidative 
phosphorylation. 
 
 In normal livers, the levels of reactive oxygen species are low and there are adequate 
antioxidant defenses to prevent oxidative damage (Fernandez-Checa J et al, 1997). 
Animal studies on oxidative stress and antioxidant defenses in the normal liver following 
PH have been performed. Mitochondrial GSH has been observed to decrease after PH 
(Guerrieri F et al, 1999 and Vendemiale G et al, 1995), while mitochondrial oxidant 
production is increased (Lee F et al, 1999). However, there are conflicting data on the 
levels of mitochondrial lipid peroxidation. Increased and unchanged malondialdehyde 
production had been described in two different studies (Guerrieri F et al, 1999 and 
Aguilar-Delfin I et al, 1996).  
 
Studies using cirrhotic rat livers have demonstrated that cirrhotic livers have an impaired 
capacity to respond to oxidative stress (Cabre M et al, 2000 and Balkan J et al, 2001). 
However, it is unclear how this will influence the liver regenerative process following 
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PH. Hence, the aim of this study is to investigate both mitochondrial and cytosolic 



















5.2 Mitochondrial and cytosolic antioxidant capacity in normal and 
cirrhotic livers 
Within the mitochondria, enzymes involved in antioxidant defenses include catalase, 
superoxide dismutase (SOD) and glutathione peroxidase. The mitochondrial and 
cytosolic activities of SOD and glutathione peroxidase as well as that of glutathione 
reductase and the mitochondrial and total hepatic GSH levels were analyzed as described 
in section 2.12, 2.13, 2.14 and 2.11, using submitochondrial particles and the liver 
cytosolic fraction. The expression of catalase was analyzed by western blotting as 
described in section 2.16, also using submitochondrial particles and the cytosolic fraction. 
30 animals were used in both normal group and cirrhotic group. In cirrhotic livers, total 
hepatic GSH levels were not significantly different from controls but mitochondrial GSH 
levels were significantly lower. There were no significant differences in the 
mitochondrial and cytosolic SOD activities between the two groups. However, 
mitochondrial and cytosolic glutathione peroxidase activities were significantly lowered 
in the cirrhotic group. In contrast, mitochondrial and cytosolic glutathione reductase 
activities were significantly higher. There was no significant difference in the 
mitochondrial catalase expression between the two groups, but the cytosolic catalase 





















Mt GSH (nmol/mg protein) 
 
 
7.6 + 0.2 
 
1.9 + 0.1* 
 
Hepatic GSH (nmol/mg protein) 82.0 + 2.8 98.8 + 2.7 
 
Mt SOD activity (U/mg protein)  18.5 + 0.8 
 
15.0 + 1.3 
 
Cyto SOD activity (U/mg protein) 
 
47.4 + 0.9 39.5+0.8 
Mt GPx activity (nmol/min/mg protein) 
 
301.7 + 11.3 189.1 + 7.6* 
 
Cyto GPx activity (nmol/min/mg protein) 
 
634.8 + 9.6 375.4+13.0* 
Mt GRd activity (nmol/min/mg protein) 
 
23.2 + 1.1 36.3 + 2.0* 
 
Cyto GRd activity (nmol/min/mg protein) 
 
57.6 + 1.7 114.3+2.6* 
Mt catalase expression (AU) 
 
0.60 + 0.07 0.75 + 0.04 
Cyto catalase expression (AU) 
 
1.25 + 0.04 0.76 + 0.04* 
 
 
Data are presented as mean + S.E.M. of 30 animals in each group. Liver homogenates 
were used to determine the hepatic GSH level. Submitochondrial particles were used to 
determine the mitochondrial GSH level, glutathione peroxidase (GPx), glutathione 
reductase (GRd) and SOD activities. *Compared with group 1, p<0.05, student’s t-test 




5.3 Changes in mitochondrial and cytosolic antioxidant capacity 
following partial hepatectomy 
6 animals were used in both normal group and cirrhotic group for each time point.  
 
5.3.1 Mitochondrial and hepatic GSH level 
Following PH, mitochondrial GSH levels decreased at 3 h and 6 h but returned to pre-
hepatectomy levels at 24 h in controls (Fig 5.1A). A transient drop at 3 h followed by a 
peak at 24 h in total hepatic GSH levels was also observed for the controls (Fig 5.1B).  In 
the cirrhotic group, mitochondria GSH levels were consistently lower than that of 
controls at all time points (Fig 5.1A) even though there were no significant differences in 
total hepatic GSH levels between the two groups of animals throughout the experimental 
time frame (Fig 5.1B).   
 
5.3.2 Mitochondrial and cytosolic superoxide dismutase activity 
In the healthy controls, mitochondrial and cytosolic SOD activities were not affected by 
PH. In the cirrhotic group, mitochondria SOD activities were significantly lower than that 
of the control at 24 h post-PH, while the cytosolic SOD activities were lower than 







































Fig 5.1A Mitochondrial glutathione (GSH) content in control (solid line) and 
cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + S.E.M. from 
six rats in each group) are expressed as percent of control at 0h (100%). Control GSH 
content was determined from the excised livers (at 0h) of all control rats (n=30) used in 
the study. The control mitochondrial GSH level was 7.6 + 0.2 nmol/mg protein. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 











































Fig 5.1B Hepatic glutathione (GSH) content in control (solid line) and cirrhotic rats 
(broken lines) after partial hepatectomy. Results (mean + S.E.M. from six rats in each 
group) are expressed as percent of control at 0h (100%). Control GSH content was 
determined from the excised livers (at 0h) of all control rats (n=30) used in the study. The 
control hepatic GSH level was 82.0 + 2.8 nmol/mg protein. *p<0.05, ANOVA analysis, 










































Fig 5.2A Mitochondrial superoxide dismutase (SOD) activity from control (solid 
line) and cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + 
S.E.M. from six rats in each group) are expressed as percent of control activity at 0h 
(100%). The control activity was determined from the excised livers (at 0h) of all control 
rats (n=30) used in the study. Control value was 18.5 + 0.8 U/mg protein. #p<0.05, 
ANOVA analysis, for comparison between the cirrhotic group and the corresponding 















































Fig 5.2B Cytosolic superoxide dismutase (SOD) activity from control (solid line) and 
cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + S.E.M. from 
six rats in each group) are expressed as percent of control activity at 0h (100%). The 
control activity was determined from the excised livers (at 0h) of all control rats (n=30) 
used in the study. Control value was 47.4 + 0.9 U/mg protein. #p<0.05, ANOVA analysis, 











5.3.3 Mitochondrial and cytosolic glutathione peroxidase activity 
In controls, mitochondrial GPx activity was significantly reduced at 24 h and 48 h post-
PH, while the cytosolic GPx activity was only reduced at 48 h post-PH. In the cirrhotic 
group, both mitochondrial GPx and cytosolic GPx activities were consistently lower than 
those of the controls both before and up to 72 h post-PH (Fig 5.3A-B). 
 
5.3.4 Mitochondrial and cytosolic glutathione reductase activity 
In the controls, both mitochondrial GRd and cytosolic GRd activities were not affected 
by PH. However, in the cirrhotic group, mitochondria GPd activity was comparable or 
even higher than that for controls. Higher cytosolic glutathione reductase activities were 
also observed both before and after PH in the cirrhotic liver (Fig 5.4A-B). 
 
5.3.5 Mitochondrial and cytosolic catalase expression  
Mitochondrial and cytosolic catalase expressions were analyzed by western blotting as 
described in section 2.16. Results are shown in Fig 5.5A-B. The expression of 
mitochondria catalase expression increased at 6 hours post hepatectomy, but there is no 
significant difference between normal and cirrhotic rats up to 72 h post hepatectomy. 
However, the cytosolic catalase expression is different from that observed for the 
mitochondrial enzyme. The cytosolic catalase levels of normal rats were significantly 














































Fig 5.3A Mitochondrial glutathione peroxidase (GPx) activity from control (solid 
line) and cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + 
S.E.M. from six rats in each group) are expressed as percent of control activity at 0h 
(100%). The control activity was determined from the excised livers (at 0h) of all control 
rats (n=30) used in the study. Control value was 301.7 + 11.3 nmol/min/mg protein. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 



















































Fig 5.3B Cytosolic glutathione peroxidase (GPx) activity from control (solid line) 
and cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + S.E.M. 
from six rats in each group) are expressed as percent of control activity at 0h (100%). The 
control activity was determined from the excised livers (at 0h) of all control rats (n=30) 
used in the study. Control value was 634.8 + 9.6 nmol/min/mg protein. *p<0.05, ANOVA 
analysis, for comparison between control rats before (at 0h) and after PH. #p<0.05, 
ANOVA analysis, for comparison between the cirrhotic group and the corresponding 



















































Fig 5.4A Mitochondrial glutathione reductase (GRd) activity from control (solid 
line) and cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + 
S.E.M. from six rats in each group) are expressed as percent of control activity at 0h 
(100%). The control activity was determined from the excised livers (at 0h) of all control 
rats (n=30) used in the study. Control value was 23.2 + 1.1 nmol/min/mg protein. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 





















































Fig 5.4B Cytosolic glutathione reductase (GRd) activity from control (solid line) and 
cirrhotic rats (broken lines) after partial hepatectomy. Results (mean + S.E.M. from 
six rats in each group) are expressed as percent of control activity at 0h (100%). The 
control activity was determined from the excised livers (at 0h) of all control rats (n=30) 
used in the study. Control value was 57.6 + 1.7 nmol/min/mg protein. #p<0.05, ANOVA 
analysis, for comparison between the cirrhotic group and the corresponding control group 
































Fig 5.5A Western blot analysis of mitochondrial catalase expression in normal (solid 
line) and cirrhotic rats (broken lines) after partial hepatectomy. For each time point, 
the mitochondria from 6 animals were pooled and used for Western blot analysis. The 
blot image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative blot (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean + S.E.M (AU = arbitrary units) are 
shown. *p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) 








































Fig 5.5B Western blot analysis of cytosolic catalase expression in normal (solid line) 
and cirrhotic rats (broken lines) after partial hepatectomy. At different time points 
after the operation, the remnant liver was harvested, homogenized and the supernatant 
was used for analysis. For each time point, the supernatant from 6 animals was pooled 
and used for Western blot analysis. The blot image was captured and the bands were 
quantified using the Analytical Imaging Station software. All analyses were carried out in 
triplicates. A representative blot (C, control, healthy rats; E, cirrhotic rats; the number 
indicates the time post-PH in hours) and the quantification analysis expressed as 
mean+S.E.M (AU = arbitrary units) are shown. *p<0.05, ANOVA analysis, for 
comparison between control rats before (at 0h) and after PH. #p<0.05, ANOVA analysis, 







5.3.6 Mitochondrial lipid peroxidation 
Lipid peroxidation was assessed using the thiobarbituric acid-reacting substances 
(TBARS) assay as shown in section 2.15. The only significant rise was observed in the 
mitochondria of cirrhotic rats at 24 h post-PH (Fig 5.6). This coincides with a 
significantly lowered mitochondria SOD activity at the same time point. 
 
5.4 Conclusions 
Prior to PH, livers from cirrhotic animals have significantly lowered mitochondrial GSH 
levels, lowered mitochondrial and cytosolic GPx activities and elevated mitochondrial 
and cytosolic GRd activities when compared to control animals. Following PH, 
mitochondrial GSH levels, mitochondrial and cytosolic GPx activities remained 
persistently lower than controls, while GRd activities remained elevated. In addition, 
cytosolic SOD activities and catalase expression were also lowered post PH. Thus, when 
compared to the controls, cirrhotic livers indeed have diminished impaired antioxidant 
defenses following PH. The impaired antioxidant system in cirrhotic livers may in turn 
generate more oxidative stress and cause damage to the liver. This factor, if critical, could 































Fig 5.6 Mitochondrial TBARS level from control (solid line) and cirrhotic rats 
(broken lines) after partial hepatectomy. Results (mean + S.E.M. from six rats in each 
group) are expressed as percent of control activity at 0h (100%). The control 
concentration was 1.84 + 0.05 nmol malondialdehyde (MDA) /mg mitochondrial protein 
and was determined from the excised livers (at 0h) of all control rats (n=30) used in the 
study. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 












A healthy liver has the capacity to regenerate itself after injury. This results in the 
restoration of liver mass and function (Fausto N et al, 1995 and Michalopoulos GK et al, 
1997). In the healthy state, hepatocytes are in the resting G0 state and rarely divide. 
However, following injury or hepatectomy, the process of regeneration is activated. 
Hepatocytes then undergo transition into the G1 phase, followed by the S phase, G2 
phase and mitosis. The passage through the cell cycle is modulated by the interplay 
between cyclins, cyclin-dependent kinases (cdks) and inhibitors of cdks (Loyer P et al, 
1994; Albrecht JH et al, 1993; Ehrenfried JA et al, 1997 and Albrecht JH et al, 1998).   
 
Liver regeneration is influenced by a multitude of factors. These include cytokines and 
growth factors which are necessary to make quiescent hepatocytes replicate (Fausto N et 
al, 1995; Michalopoulos GK et al, 1997 and Taub R, 2004). It has now been established 
that a set of priming events is necessary before the normally quiescent hepatocytes can 
respond to the growth factors. Both tumor necrosis factor-α (TNF-α) and interleukin-6 
(IL-6) have been shown to be the factors that facilitate the priming events in regeneration 
(Akerman P et al, 1992 and Streetz KL et al, 2000). Following the priming events, 
growth factors then play an important role as mitogens generating a cascade of signals 
leading to DNA synthesis and cell division (Fausto N et al, 1995).  
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 In humans, surgical resection is often carried out on a diseased liver and is the main 
therapeutic intervention for hepatocellular carcinoma (Kanematsu T et al, 1984). The 
remnant liver is usually cirrhotic with impaired regenerative capacity. In this part of the 
study, the differences in the responses of normal and cirrhotic livers to PH in relation to 
the factors influencing hepatocyte proliferation and division were examined. The 
thioacetamide-induced rodent model of liver cirrhosis was employed as induction of 
cirrhosis with thioacetamide is highly reproducible, irreversible and produces 


















6.2 Hepatic TNF-α and IL-6  
Two groups of animals were used in the study. In the control group, healthy rats were 
submitted to 70% PH. In the cirrhotic group, animals were treated with thioacetamide, 
leading to the development of cirrhosis and these animals were similarly subjected to 
70% PH. All data generated in this study were first examined to determine the changes 
that occur after PH in the controls. This was followed by comparisons to determine if 
there were significant differences between the controls group and the cirrhotic group both 
before and after 70% PH. At different time points after the operation, the remnant liver 
was harvested, homogenized and the supernatant was used for analysis. For each time 
point, the supernatant from 6 animals was pooled and used for ELISA analysis. 
 
6.2.1 TNF-α level 
Cytosolic TNF-α level was analyzed by ELISA as described in section 2.17.1. Prior to 
PH, TNF-α was detected in the normal and cirrhotic livers. The levels in cirrhotic livers 
were significantly lower than those in healthy livers. Following resection, the hepatic 
levels of TNF-α were significantly lowered from 3 hours till 72 hours post-resection in 
the control group. Significantly differences in TNF-α levels between the controls and 
cirrhotics were only observed at 24h and 48h post-PH (Fig 6.1). 
 
6.2.2 IL-6 level 
Cytosolic IL-6 level was also analyzed by ELISA as described in section 2.17.2. Prior to 
PH, IL-6 was detected in the normal and cirrhotic livers. The levels in cirrhotic livers 
were significantly lower than those in healthy livers. Following resection, the hepatic 
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levels of IL-6 were significantly lowered from 3 hours till 72 hours post-resection in the 
control group. Reduced IL-6 levels were observed in the cirrhotic group before and up to 
72 hours following PH (Fig 6.2). 
 
6.3 Expression of growth factors 
At different time points after the operation, the remnant liver was harvested, and RNA 
was extracted using TRIZOL as described in section 2.18.1. For each time point, the 
RNA from 6 animals was pooled and used for reverse-transcription followed by PCR as 
described in section 2.18.2. The PCR product was separated by agarose-gel 
electrophoresis and visualized by ethidium-bromide staining. The gel image was captured 
and the bands were quantified using the Analytical Imaging Station software. The 28S 
rRNA served as the control. There was no significant difference in 28S rRNA level 
between normal and cirrhotic rats both before and after PH (Fig. 6.3). 
 
6.3.1 HGF mRNA 
A transient increase in HGF was observed at 6 hours post-PH for the control group. The 
trend was also similar for the cirrhotic group, although a significant increase was also 
observed at 3 hours post-PH (Fig 6.4). 
 
6.3.2 TGF-α mRNA 
TGF-α was significantly higher at all time points post-resection in the control group. 
TGF-α level in the cirrhotic livers was significantly higher than controls before PH. After 
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PH, the levels remained high and there were no differences between the control group 
and the cirrhotic group (Fig 6.5). 
 
6.4 Expression of cyclins 
At different time points after the operation, the remnant livers were harvested, 
homogenized and the supernatants were used for analysis. For each time point, the 
supernatants from 6 animals were pooled and used for Western blot analysis as described 
in section 2.16. The blot image was captured and the bands were quantified using the 
Analytical Imaging Station software. 
  
6.4.1 Expression of cyclin D1 
Before hepatectomy, and at 3 and 6 h post-PH, the expression of cyclin D1 in cytosol of 
both normal and cirrhotic rats were very low. Cyclin D1 levels were elevated from 24 to 
72 h post-PH in the control group. Comparison of the cirrhotic group with the 
corresponding controls showed that cyclin D1 levels were significantly lower at 24 to 72 
hours post-PH (Fig 6.6). 
 
6.4.2 Expression of cyclin D3 
In control rats, cyclin D3 levels increased at 6 h, peaked at 24 h post-PH and remained 
significantly elevated up till 72 h post-PH. In contrast, the peak in cyclin D3 expression 






































Fig 6.1 Hepatic TNF-α concentration after PH on healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, homogenized and the supernatant was used for analysis. For each time 
point, the supernatant from 6 animals was pooled and used for ELISA analysis. All 
analyses were carried out in triplicates and the results are expressed as mean ± SD. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 








































Fig 6.2 Hepatic IL-6 concentration after PH on healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, homogenized and the supernatant was used for analysis. For each time 
point, the supernatant from 6 animals was pooled and used for ELISA analysis. All 
analyses were carried out in triplicates and the results are expressed as mean ± SD. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 
































Fig 6.3 Hepatic 28S rRNA expression after PH on healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, and RNA was extracted. For each time point, the RNA from 6 animals 
was pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
































Fig 6.4 Hepatic HGF expression after PH on healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, and RNA was extracted. For each time point, the RNA from 6 animals was 
pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 
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Fig 6.5 Hepatic TGF-α expression after PH on healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, and RNA was extracted. For each time point, the RNA from 6 animals 
was pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 
































Fig 6.6 Effect of PH on cyclin D1 expression in healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, homogenized and the supernatant was used for analysis. For each time 
point, the supernatant from 6 animals was pooled and used for Western blot analysis. The 
blot image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative blot (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 






































Fig 6.7 Effect of PH on cyclin D3 expression in healthy rats (white bars) and 
cirrhotic rats (black bars). At different time points after the operation, the remnant liver 
was harvested, homogenized and the supernatant was used for analysis. For each time 
point, the supernatant from 6 animals was pooled and used for Western blot analysis. The 
blot image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative blot (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. 
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 







6.4.3 Expression of cyclin E 
As previously described, the antibody against cyclin E recognized multiple isoforms 
(Jaumot M et al, 1999 and Albrecht JH et al, 1999). These represent alternative spliced 
variants of the gene. Cyclin E levels in the controls increased significantly within 24 
hours following resection. However, in the cirrhotic group, this increase was not evident 
and cyclin E levels were lower than the controls at all time points (Fig 6.8). 
 
6.4.4 Expression of cyclin A 
Before hepatectomy, and at 3 and 6 h post-PH, the expression of cyclin A in both normal 
and cirrhotic rats were very low. For the control animals, the highest levels of cyclin A 
expression were at 24 and 48 h after resection. At these time points, the levels of cyclin A 
in cirrhotic rats were significantly lower when compared to the corresponding controls 
(Fig 6.9). 
 
6.5 Expression of cdks 
Expression of cdks was also analyzed by western blotting as described in section 2.16. 
 
6.5.1 Expression of cdk4 
The expression of cdk4 in control rats significantly increased at 6 h post-PH. This 
correlates with the increased cyclin D3 expression at 6 h post-PH. In cirrhotic group the 
cdk4 levels were lower than those of the corresponding controls from 6 to 72 hours post-

































Fig 6.8 Effect of PH on cyclin E expression in healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, homogenized and the supernatant was used for analysis. For each time point, 
the supernatant from 6 animals was pooled and used for Western blot analysis. The blot 
image was captured and the bands were quantified using the Analytical Imaging Station 
software. All analyses were carried out in triplicates. A representative blot (C, control, 
healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) and the 
quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 

































Fig 6.9 Effect of PH on cyclin A expression in healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, homogenized and the supernatant was used for analysis. For each time point, 
the supernatant from 6 animals was pooled and used for Western blot analysis. The blot 
image was captured and the bands were quantified using the Analytical Imaging Station 
software. All analyses were carried out in triplicates. A representative blot (C, control, 
healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) and the 
quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 
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Fig 6.10 Effect of PH on cdk4 expression in healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, homogenized and the supernatant was used for analysis. For each time point, 
the supernatant from 6 animals was pooled and used for Western blot analysis. The blot 
image was captured and the bands were quantified using the Analytical Imaging Station 
software. All analyses were carried out in triplicates. A representative blot (C, control, 
healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) and the 
quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 






6.5.2 Expression of cdk2 
For the control animals, the highest levels of cdk2 expression were at 24 and 48 h after 
resection. At these time points, the levels of cdk2 in cirrhotic rats were significantly 
lower than that in the corresponding controls. Cyclin A binds and activates cdk2. The 
expression pattern of cdk2 was similar to that of cyclin A (Fig 6.11).   
 
6.6 mRNA of cdk inhibitors 
mRNA level of cdk inhibitors was also analyzed by RT-PCR as described in section 
2.18.2.  
 
6.6.1 p21 mRNA 
For the controls, the p21 mRNA levels increased shortly after PH (at 3 and 6 h) but 
returned to pre-resection levels after 24 h. For the cirrhotic rats, the changes observed 
were similar to those of the controls, although the increase in p21 levels at 3 h post PH 
was significantly higher (Fig 6.12).  
 
 6.6.2 p27 mRNA 
Prior to PH, the p27 mRNA levels of cirrhotic rats were significantly higher than the 
healthy controls. Following PH, the p27 levels in the cirrhotic group continued to be 

























Fig 6.11 Effect of PH on cdk2 expression in healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, homogenized and the supernatant was used for analysis. For each time point, 
the supernatant from 6 animals was pooled and used for Western blot analysis. The blot 
image was captured and the bands were quantified using the Analytical Imaging Station 
software. All analyses were carried out in triplicates. A representative blot (C, control, 
healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) and the 
quantification analysis expressed as mean+SE (AU = arbitrary units) are shown. *p<0.05, 
ANOVA analysis, for comparison between control rats before (at 0h) and after PH. 
#p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 

































Fig 6.12 Hepatic p21 expression after PH on healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, and RNA was extracted. For each time point, the RNA from 6 animals was 
pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown.  
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 
corresponding control group at each time point. 
 


































Fig 6.13 Hepatic p27 expression after PH on healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, and RNA was extracted. For each time point, the RNA from 6 animals was 
pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown.  
*p<0.05, ANOVA analysis, for comparison between control rats before (at 0h) and after 
PH. #p<0.05, ANOVA analysis, for comparison between the cirrhotic group and the 







6.7 p53 mRNA 
The expression of p53 was also analyzed by RT-PCR as described in section 2.18.2.  
The p53 mRNA level of normal rats increased at 6 hours post hepatectomy. There was no 
significant difference at each time point between normal and cirrhotic rats in p53 mRNA 
level (Fig 6.14).  
 
6.8 Conclusions 
The data from our study suggest that the low expression of cyclins and cdks might exert a 
considerable negative effect on liver regeneration in cirrhotic remnants. This hypothesis 
is supported by the evidence that the IL-6 levels are low in cirrhotic remnant and this 
could in turn influence the actions of transcription factors that regulate genes involved in 



























Fig 6.14 Hepatic p53 expression after PH on healthy rats (white bars) and cirrhotic 
rats (black bars). At different time points after the operation, the remnant liver was 
harvested, and RNA was extracted. For each time point, the RNA from 6 animals was 
pooled and used for reverse-transcription followed by PCR. The PCR product was 
separated by agarose-gel electrophoresis and visualized by ethidium-bromide staining. 
The gel image was captured and the bands were quantified using the Analytical Imaging 
Station software. All analyses were carried out in triplicates. A representative gel (C, 
control, healthy rats; E, cirrhotic rats; the number indicates the time post-PH in hours) 
and the quantification analysis expressed as mean+SE (AU = arbitrary units) are shown.  









7.1 Respiratory enzymes activities in normal and cirrhotic livers 
In a healthy liver, energy required for all cellular processes is supplied by the 
mitochondria through the process of oxidative phosphorylation. A series of enzyme 
complexes are involved in this process which couples the oxidation of the electron 
donors, NADH or FADH2 with ATP synthesis from ADP and inorganic phosphate. Using 
rodent models of cirrhosis, changes in mitochondrial functions have been observed in 
cirrhotic livers. This includes the loss of respiratory control in the presence of a NADH-
linked substrate, glutamate (Krahenbuhl S et al, 1989 and Nozu F et al, 1992), or a 
FADH2-linked substrate, succinate (Nozu F et al, 1992). In this study, liver cirrhosis in 
rats was induced with thioacetamide and the activities of respiratory enzyme complexes 
were first examined. In cirrhotic livers, NCCR activities were significantly reduced, 
suggesting that NADH-linked oxidation may be impaired as previously reported 
(Krahenbuhl S et al, 1989 and Nozu F et al, 1992). However, in our study, succinate-
linked respiration was not affected by cirrhosis. In agreement with this observation, all 
complexes involved in FADH2-linked oxidative phosphorylation namely SCCR, CCO 
and ATPase activities were also unchanged. This is in contrast to previous observations 
(Nozu F et al, 1992) and may be due to allowing the rats access to food prior to sacrifice. 
Feeding leads to greater degree of coupling of oxidative phosphorylation (Soboll S et al, 
1985) and in this study, the animals were allowed free access to food. Similar 
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observations have been made in the carbon-tetracholoride induced model of cirrhosis 
(Krahenbuhl S et al, 1989). The RCR was reduced in mitochondria from cirrhotic livers 
with β-hydroxybutyrate as substrate but not with succinate. This also concurs with 
previous observations that complex I is more susceptible to damage than complex II and 
complex III (Cederbaum A et al, 1974 and Bottenus R et al, 1982). 
 
7.2 Changes in mitochondrial respiratory enzymes and ATPase 
following hepatectomy 
 
a) Changes in control livers  
State 3 and State 4 respiration decreased to the lowest level at 6 h post-PH. This may be 
due to tissue damage caused by the transient elevation of free radicals in the early phase 
of liver regeneration. Following hepatic resection, there is increased ATP demand due to 
loss of liver mass and the needs of the regenerative process. In normal rat liver remnants, 
the energy charge potential as well as liver ATP levels had been shown to decrease 
significantly at 24h post-PH (Morimoto T et al, 1992 and Kurokawa T et al, 1991). 
Changes in mitochondrial functions have also been observed. These include changes in 
RCR (Tsai J et al, 1992 and Hernandez-Munoz R et al, 2003). In this study, as well in 
other earlier studies using rats (Hernandez-Munoz R et al, 2003, Morimoto T et al, 1992 
and Kurokawa T et al, 1991), a peak in RCR was observed at 24h post-PH in normal liver 
remnants. CCO activities were also enhanced from 24 h till 72 h post-PH and this may 
represent the initial steps in mitochondria biogenesis (Krahenbuhl S et al, 1992). Both 
these changes will lead to enhancement of phosphorylation rates, which was also 
maximal at 24h post-PH (Morimoto T et al, 1992). The increase in the RCR and CCO are 
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probably adaptive measures to enhance mitochondrial ATP-synthesizing activity as the 
increase in RCR and phosphorylation rate coincides with low levels of liver ATP 
(Morimoto T et al, 1992 and Kurokawa T et al, 1991).  
 
b) Changes in cirrhotic livers 
A key difference between the normal and cirrhotic livers post-PH was the significantly 
lowered NCCR activity both before and after hepatectomy, which would diminish 
NADH-linked respiration. In contrast to normal liver remnants, the lower SCCR activity 
in cirrhotic liver would lead to impaired FADH2-linked oxidative phosphorylation, which 
is consistent with the significantly lower RCR in the cirrhotic group (This study and 
Kurokawa T et al, 1991) than that of the corresponding controls indicating a higher 
degree of uncoupling of oxidative phosphorylation. Taken together, this would account 
for the absence of enhancement of phosphorylation rates in cirrhotic livers after PH 
(Morimoto T et al, 1992) and contribute to the depressed energy status and low ATP 
levels after hepatectomy (Mann D et al, 2001, Morimoto T et al, 1992 and Kurokawa T et 
al, 1991). This will in turn result in a less efficient regeneration process and may even 
cause liver failure if the degree of histologic damage in the remnant liver is high and 
oxidative phosphorylation is greatly impaired. 
 
7.3 Mitochondrial and cytosolic antioxidant capacity in normal and 
cirrhotic livers 
 
The process of oxidative phosphorylation can result in the generation of reactive oxygen 
species as byproducts. The reaction catalyzed by superoxide dismutase is the first step in 
dealing with oxidative stress. This removes the superoxide anion and generates hydrogen 
 122
peroxide which is then reduced to water by catalase and glutathione peroxidase, a 
selenoprotein, using GSH as the cosubstrate. The oxidized glutathione is then reduced by 
glutathione reductase back to GSH (Fernandez-Checa J et al, 1997). In this 
thioacetamide-induced model of cirrhosis, the mitochondrial and cytosolic antioxidant 
defenses were impaired although mitochondrial lipid peroxidation was not significantly 
increased, similar to that observed in the study by Hernandez-Munoz et al (Hernandez-
Munoz R et al, 1997). Although the activities of mitochondrial SOD (also known as Mn-
SOD) and cytosolic SOD (also known as Cu, Zn-SOD) were not affected, mitochondrial 
and cytosolic glutathione peroxidase activity as well as cytosolic catalase expression 
were significantly decreased in the cirrhotic liver. The decrease of glutathione peroxidase 
activity may be due to the loss of selenium from the liver following chronic 
thioacetamide treatment (Balkan J et al, 2001 and Al-Bader A et al, 1998).  
 
Mitochondrial GSH levels in the cirrhotic liver were significantly lower than in the 
control. The decreased mitochondrial GSH level was not due to impaired regeneration of 
oxidized GSH as mitochondria glutathione reductase was significantly higher than or 
similar to controls. In addition, similar to previous observations (Hernandez-Munoz R et 
al, 1997 and Muller D et al, 1991), total hepatic GSH levels were not different from 
controls. Thus, the lowered mitochondria GSH levels may be attributed to an impaired 
transport of GSH from the cytoplasm into the mitochondria or an increased utilization of 






7.4 Changes in mitochondrial and cytosolic antioxidant capacity 
following partial hepatectomy 
 
a) Changes in the control group 
An increase in oxygen free radicals have been shown to occur during liver regeneration 
after PH (Tsai J et al, 1992). In addition, TNF-α which has growth-stimulatory effects 
after hepatectomy, also increases mitochondrial oxidant production (Lee F et al, 1999). In 
the early phase of regeneration in normal remnants (before 24 h post-PH), decreased 
mitochondrial and hepatic GSH levels were observed (Figure 5.1A , 5.1B and Guerrieri F 
et al, 1999) probably as a consequence of the increased oxidant production (Tsai J et al, 
1992 and Lee F et al, 1999). Following an initial drop in hepatic GSH levels at 3 h post-
PH, increases were observed from 24 h till 72 h post PH. Both a normal baseline hepatic 
GSH level and a subsequent increase in GSH following PH are necessary for normal 
regeneration to occur (Huang ZZ et al, 2001). The mechanism for this is currently not 
known (Huang ZZ et al, 2001) although it has been shown extensively that increased 
GSH levels are associated with an early proliferative response and are essential for the 
cells to enter S phase (Messina J et al, 1989 and Poot M et al, 1995). DNA synthesis 
requires increased concentration of GSH or thiols. This may be because proliferating 
cells require increased pentose and thiols. DNA synthesis involves the formation of 
pentoses and their conversion to deoxyribose by ribonucleotide reductase. The activity of 
this enzyme requires reduced glutaredoxin or thioredoxin. The reduced states of these 
molecules are maintained by oxidation of GSH to GSSG or oxidation of NADPH to 
NADP (Huang ZZ et al, 1998). The increase in GSH may also change the thiol-redox 
status of the hepatocyte, leading to the activation of genes for G1/S transition.  
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Despite the initial decrease in GSH levels after PH in normal livers, there was no increase 
in lipid peroxidation in the mitochondria, similar to observations made in an earlier study 
(Aguilar-Delfin I et al, 1996).  
 
Mitochondrial and cytosolic SOD and glutathione reductase activities were not affected 
by PH. However, decreased mitochondrial glutathione peroxidase activities at 24h and 
48h post-PH as well as decreased cytosolic glutathione peroxidase activity at 48 h post-
PH were observed. Although it is unclear why this occurs, it has been shown that 
glutathione peroxidase can be inactivated by a variety of physiological substances 
including nitric oxide. Thus, the decreased activity may be the result of inactivation of the 
peroxidase by nitric oxide which is released in the regenerating liver after PH (Hortelano 
S et al, 1995 and Miyamoto Y et al, 2003).   
 
b) Changes in the cirrhotic group 
Cirrhotic livers had significantly lower mitochondrial GSH as well as lower 
mitochondrial glutathione peroxidase activities. Following hepatectomy, hepatic GSH 
levels were not different from controls but both mitochondrial GSH and glutathione 
peroxidase activity remained depressed up to 72 h post-PH. Cytosolic catalase expression 
also remained depressed except at 6 h post-PH. In addition, a significant decrease in 
cytosolic SOD activity from 6 h to 48 h post-PH and mitochondrial SOD activity at 24 h 
post PH together with increased lipid peroxidation was also observed in the cirrhotic 
remnants (in this study and Morimoto T et al, 1992). Thus unlike the control, the cirrhotic 
remnant has less capacity to provide antioxidant defense following PH. 
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7.5 Expression of cyclins, cdks and cdk inhibitors in normal and 
cirrhotic livers 
 
Cyclins, cdks and cdk inhibitors were all detected in healthy livers, similar to previous 
observations (Jaumot M et al, 1999). Cirrhotic livers also expressed comparable levels of 
D-type cyclins, cyclin A, cdks, p21 and p53 as the healthy livers. However, cyclin E was 
significantly lowered while p27 was significantly raised.   
 
7.6 Changes in expression of cyclins, cdks and cdk inhibitors after PH 
a) Changes in the controls 
Following PH, quiescent hepatocytes are induced to proliferate. Cyclins and their kinase 
partners play key roles in regulating the progress through the different phases of the cell 
cycle (Vermeulen K et al, 2003 and Murray AW, 2004). The D-type cyclins together with 
their kinase partners play a key role in regulating G1 progression (Sherr CJ, 1994). The 
cyclinE/cdk2 complex regulates G1 to S phase transition (Ohtsubo M et al, 1995), while 
the cyclinA/cdk2 complex is necessary for initiation of DNA replication in the S phase 
(Girard F et al, 1991; Walker DH et al, 1991 and Woo RA et al, 2003). As expected, the 
expression of cyclin D1, cyclin E and cyclin A increased significantly in the controls 
after resection as the liver undergoes regeneration. This is congruent with other studies 
which showed that after PH, there is firstly an induction of G1 cyclins preceding S phase 
and subsequent induction of cyclin A and cyclin B (Albrecht JH et al, 1993; Lu XP et al, 
1992 and Trembley JH et al, 1994).  
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Transient increases in the mRNA levels of cdk inhibitors p21 and p27, as well as p53 
were also observed at 3-6h after PH in the controls. Similar observations have been 
previously described in various other studies using rodent models (Albrecht JH et al, 
1998; Rininger JA et al, 1997; Albrecht JH et al, 1997; Kubin T et al, 1995 and Inoue Y 
et al, 2002). It is thought that in the regenerating liver, p53 plays a dual role (Inoue Y et 
al, 2002). The first is as a cell cycle check resulting in a delay in the G1 phase to allow 
damage repair (Kubin T et al, 1995). The second is the induction of the expression of 
growth factors or their receptors. Indeed, p53 responsive elements have been found on 
the promoters of HGF and TGF-α, both of which are involved in the proliferative 
response (Shin TH et al, 1995 and Metcalfe AM et al, 1997). The expression of the cdk 
inhibitor, p21 is also induced post PH, probably in part as a response to p53 induction (el-
Deiry WS et al, 1993). This may serve to prevent premature progression through G1 
phase (Nakanishi M et al, 1995) or to stabilize the cyclinD-cdk4 complex and promote its 
translocation to the nucleus (LaBaer J et al, 1997). p27 acts as a brake on cyclinE-cdk2 
activity and has to be sequestered by cyclin D1 for cdk2 to be active (Pujol MJ et al, 
2000).   
 
b) Changes in the cirrhotic group 
Comparison between the control and cirrhotic groups showed that the changes in 
cyclin/cdk expressions after PH were not mirrored in the cirrhotic livers. Cyclin D1 and 
its kinase partner, cdk4 were expressed at much lower levels at 24-72h post PH, cyclin A 
and cdk2 were decreased at 24-48h post PH while cyclin E was persistently lowered up to 
72h post PH. In addition, the expression of the cdk inhibitory protein, p27 was also 
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elevated at 6-48h post PH.  Thus, unlike healthy livers, cirrhotic livers expresses 
significantly lower levels of cyclins (this study; Zhao G et al, 2002 and Masson S et al, 
1999). Given the persistent low levels of G1 cyclins, it is likely that the block to cell 
cycle progression occurs at the G1 phase.  
 
7.7 Expression of cytokines and growth factors in normal and cirrhotic 
livers 
 
The key factors that influence liver regeneration include the cytokines TNF-α and IL-6 
and the growth factors HGF and TGF-α. The cytokines TNF-α and IL6, are necessary to 
prime and initiate liver regeneration after PH (Fausto N, 2000; Akerman P et al, 1992 and 
Streetz KL et al, 2000). Signals to initiate liver regeneration for TNF-α are mediated by 
TNF receptor 1. Knockout mice lacking this receptor have diminished ability to restore 
liver mass after PH leading to increased mortality (Yamada Y et al, 1998). High 
postoperative mortality and impaired response to PH were also observed in IL-6 deficient 
mice (Cressman DE et al, 1996). Besides the cytokines, growth factors also play 
important roles in liver regeneration. TGF-α and HGF are potent mitogens for 
hepatocytes (Fausto N et al, 1995). The response to HGF is mediated by its interaction 
with c-met, a protooncogene which encodes a receptor tyrosine kinase. In conditional met 
mutant mice, impaired regeneration occurs after PH and this is due to a defective exit 
from quiescence and diminished entry into S phase (Borowiak M et al, 2004). In addition, 
HGF also upregulates the expression of TGF-α and the presence of anti-TGFα antibodies 
can block DNA synthesis in regenerating livers (Tomiya T et al, 2000).   
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Cirrhotic livers have significantly lower TNF-α and IL-6 levels compared to healthy 
livers prior to PH. It is unclear why this should be so. However, similar reductions have 
been observed in patients with primary biliary cirrhosis and fulminant hepatitis (Broome 
U et al, 1992; Tovey MG et al, 1991). This is not simply due to a general depression in 
RNA synthesis in the diseased livers as the expression of other genes such as IL-1 and 
interferons were unaffected (Tovey MG et al, 1991). In addition, unchecked fibrosis will 
lead to impaired diffusion of nutrient and hepatotropic factors and this may also be a 
contributing factor to the reduced levels of TNF-α and IL-6. In contrast, HGF expression 
was unchanged in cirrhotic livers. TGF-α expression was significantly increased in 
cirrhotic livers and this is consistent with the role of TGF-α in the chronic regeneration 
that occurs in the cirrhotic process (Napoli J et al, 1997). 
 
7.8 Changes in expression of cytokines and growth factors following PH 
Following resection of healthy controls, it was observed that both TNF-α and IL-6 levels 
in the liver decreased progressively over a period of 72 hours. This is to be expected as 
TNF-α and IL-6 are necessary mainly for the initial priming events. In addition, TNF-α 
is a pro-inflammatory cytokine and high levels are not desirable once the priming signals 
have been initiated.  In this study, a peak in both cytokines was not observed after PH. 
This is probably due to the fact that the increase in both cytokines was expected to be at 
an early time point after resection (Yamada Y et al, 1998 and Decker KF et al, 1995) and 
the first time point in this study may be too late for this observation. A peak in the 
expression of HGF was observed at 3-6h post PH while that of TGF-α was elevated up to 
48 hours post PH. Similar to that observed by Zhao et al, hepatic expression of the 
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growth factors HGF and TGF-α was not significantly different in both normal and 
cirrhotic livers after PH (Zhao G et al, 2002).  
 
In contrast to the growth factors, it was observed that following PH, the IL-6 levels in 
cirrhotic livers are significantly lower than that of the healthy controls. The role of IL-6 
in liver regeneration has been extensively examined. To date, the roles of IL-6 in liver 
regeneration include the activation of acute phase response, induction of proliferation and 
hepatoprotection. The binding of IL-6 to the gp130-IL-6 receptor complex results in the 
activation of Janus kinase (JAK). This in turn activates the mitogen-activated protein 
kinase (MAPK) and STAT3 signaling pathways (Taub R, 2004 and Streetz KL et al, 
2000).  In IL-6 deficient mice, liver failure and defective hepatocyte regeneration is 
observed following PH. Subcutaneous injection of IL-6 which results in sustained action 
of IL-6 was able to completely reverse the high post-operative mortality of IL-6 deficient 
mice (Blindenbacher A et al, 2003). It is interesting to note that both IL-6 and cyclin D1 
levels were reduced in the regenerating cirrhotic liver. AP1 activity was also markedly 
inhibited in regenerating cirrhotic livers with reduced expression levels of c-Jun and 
JunD (Zhao G et al, 2002). Taken together, these observations are comparable to that in 
IL-6 deficient mice which shows marked reduction in STAT3 activation and depressed 
AP-1, myc and cyclin-D1 expressions (Cressman DE et al, 1996).  
 
Il-6 also mediates the induction of C/EBP expression (Chen J et al, 1999). Impaired 
C/EBPβ activities have been observed in cirrhotic livers following resection (Zhao G et 
al, 2002) and this could account for the reduction in cyclin E and cyclin A. In C/EBPβ -/- 
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mice, cyclins A, B and D were reduced near the peak of DNA synthesis during liver 
regeneration (Greenbaum LE et al, 1998). Although it is still uncertain as to whether 
C/EBPβ regulates cyclin expression via transcriptional or post-transcriptional 
mechanisms, it is clear that in C/EBPβ -/- hepatocytes, cell cycle progression is blocked 




















Following PH, the remnant liver will regenerate resulting in the restoration of liver mass 
and liver-specific functions. However, this remarkable regeneration process is often 
impaired when the remnant liver is cirrhotic. In this study, a series of factors that may 
contribute to impaired regeneration of cirrhotic livers were examined.  
 
Changes in the expression patterns of cytokines, growth factors and cell cycle proteins 
were examined. A significant difference between the cirrhotic rats and the controls was 
the low IL-6 level. Examination of the expression of cyclins in cirrhotic livers following 
PH showed that there is lower expression of cyclins including cyclin D1 which would 
prevent a progression into the G1 phase of the cell cycle. Markedly reduced IL-6 levels 
would influence the action of transcription factors (such as STAT3, AP1, C/EBPβ and 
HNF-1α), which are necessary for the regulation of genes that coordinate the balance 
between cell proliferation and metabolic homeostasis during liver repair and growth.  
 
In addition, liver regeneration is critically dependent on ATP stores and the ability of the 
liver to synthesize ATP. By examining the various complexes involved in the 
mitochondrial oxidative phosphorylation, it was evident that in the cirrhotic liver, the 
activity of complex I is significantly reduced both before and after resection. Complex I 
(NADH-coenzyme Q reductase) is the site of entry of reducing equivalents from NADH. 
Thus, decreased complex I activity would negatively impact the generation of energy 
from various fuel sources, as the catabolism of most fuels generates substantially more 
NADH than FADH2. Besides the changes to complex I, changes in the RCR using a 
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complex II substrate was also observed after PH. This would further contribute to the 
depressed energy status. Indeed, diminished ATP production has been observed not only 
in rodent experimental models (Morimoto T et al, 1992 and Kurokawa T et al, 1991), but 
also during the regenerative process in cirrhotic livers in humans (Mann D et al, 2001).  
 
An increase in oxygen free radicals had been shown to occur during liver regeneration 
(Tsai J et al, 1992). The mechanisms in place to remove these radicals involve various 
enzymes including SOD, catalase, GPx and the availability of GSH. The data from this 
study showed that there is reduced antioxidant capacity in the cirrhotic liver both before 
and following PH. Although total hepatic GSH concentrations in the cirrhotic livers were 
similar to those of the controls, cytosolic GPx activities and catalase expressions were 
reduced in cirrhotic livers both before and after PH, while cytosolic SOD activity was 
lowered following PH in the cirrhotic livers. There was also a reduction in mitochondrial 
antioxidant capacity. This is due to reduced transport of GSH into the mitochondria as 
well as reduced mitochondrial GPx activity. This impaired mitochondria antioxidant 
system could in turn generate more oxidative stress and adversely affect the ability of the 
mitochondria to carry out their metabolic activity.  
 
Thus it is evident from this study that there is a multitude of factors that can contribute to 
the impaired regeneration of cirrhotic liver. These include oxidative stress, diminished 
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